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Summary of Final Report
Aim
The aim of this project is to determine whether comprehensive two-dimensional (2D) gas chromatography 
(GC×GC—the new technology developed at RMIT University) is suitable for routine use in a forensic laboratory 
for profiling illicit substances.
Format
This report is divided into three main parts described in detail in Chapters 1, 2 and 3, as well as a Background 
and Conclusion.
Chapter 1
Evaluation of world anti-doping agency criteria for anabolic agent analysis 
by using comprehensive two-dimensional gas chromatography/mass 
spectrometry
Steroid analysis by GCxGC was used as a model study to determine whether the method would comply with 
the strict and demanding analytical protocol for substances tested in athletes as determined by the World 
Anti-Doping Agency (WADA). The study at RMIT was one that was therefore subject to levels of scrutiny to 
ensure that it met the demands of steroid testing in a number of national laboratories around the world. The 
final result was four published papers and a new grant for continued study of different classes of WADA-
controlled substances.
Chapter 2
Organic impurity profiling of ecstasy tablets using GCxGC
GCxGC analysis of illicit substances that are of concern to police jurisdictions such as ecstasy, heroin and 
cocaine, was carried out. This Chapter focuses on ecstasy.
Chapter 3
Application of GCxGC in heroin and cocaine profiling
GCxGC analysis of heroin and cocaine as an alternative to current profiling methods is presented in this 
Chapter. GCxGC analysis offers a relatively simple, yet highly informative method for cocaine and heroin 
sample discrimination. This results in a complex profile that includes many other sample constituents that 
give additional information. Furthermore, several potential makers have also been detected in highly purified 
samples. This report describes the first ever application of GCxGC in cocaine profiling and the second one in 
heroin profiling to date.
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Background
GCxGC
GCxGC analysis can separate and detect very low levels of complex, volatile substances such as drugs 
of abuse. The new methods are based on comprehensive GC×GC, whereby a 2D presentation of volatile 
components in a sample is obtained that provides much greater separation power for the composition of 
the sample. This is achieved by using a two-column gas chromatography method, with a device called a 
modulator, located between the columns such that each component is subjected to continuous separation on 
the two columns, and separate and independent retention properties on each column are attained. The result 
is a 2D presentation of chemical constituents, much like a contour plot of each compound in 2D space.
SPME
The sample itself may consist of a complex biological matrix from which the target compound must be 
extracted from samples using a reproducible, highly accurate and specific method such as solid phase 
microextraction (SPME).
GCxGC–SPME analysis
Therefore, not only is greater separation achieved using high powered GCxGC, but also improved detection 
of compounds is realised. This significantly aids the process of visualising peaks in two dimensions, enables 
compounds to be ‘targeted’ and allows many more minor peaks to be located in a sample. These minor 
peaks now detectable using GCxGC may include ‘marker’ compounds/metabolites useful for identification 
and which provide further invaluable information such as sample origin/history, process of manufacture, 
common features that can link samples etc.
Results and detailed analysis
This is described in Chapters 1–3.
Overall conclusions and recommendations
•	 GC×GC does provide the necessary improved separation power to isolate many target steroid compounds 
for a complex urine matrix. The same can be expected for illicit drugs and studies to date suggest this to be 
true.
•	 SPME is a suitable technology for headspace analysis of organic components contained in illicit drugs.
•	 The reproducibility of the GC×GC method is adequate for supervised analysis of component identity (and 
in this respect, is similar to that of GC analysis); however, for unsupervised analysis as required for some 
chemometric methods, advanced data treatment methods such as alignment of data may be required (as is 
also the case for GC). Alignment in GC is easier than in GC×GC methods.
•	 Software is an issue for routine application of GC×GC methods and work is currently being carried out on 
this at RMIT University.
•	 If mass spectrometry detection is required for GC×GC separations, the LECO Pegasus system is the one 
that is used most often and has been used in the present research project at RMIT University. We have 
experience in use of quadrupole MS (qMS) with GC×GC (note that qMS is often believed to be not capable 
of sufficiently fast data acquisition for the very fast peaks produced by GC×GC).
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•	 The quality of library matches with the LECO ToFMS has necessitated the creation of our own in-house 
libraries for steroid compounds. This is suitable where the known steroids are available, but for general 
analysis of many compounds, this may present a challenge. Note that the LECO ToFMS appears to 
bias against higher mass spectrometry ions, but if the illicit drug profiling is limited to lower molar mass 
compounds, the National Institute of Standards and Technology (NIST) library may be adequate. Some 
literature reports suggest this to be true.
•	 A recent paper (see Appendix, ref 7) has tested the criteria for detection and identification of steroids set 
by WADA and has found that for the most part, these mandatory steroids to be detected can be suitably 
analysed by using GC×GC-ToFMS. An advantage is that full mass spectral data acquisition is available 
and so a more complete interpretation of all matrix compounds can be achieved, compared with the usual 
methods in WADA laboratories that rely on mass spectrometry operated in selected ion monitoring mode.
•	 Considerable differences have been found in the analysis of ecstasy, heroin and cocaine by using our 
SPME-GC×GC technology and while one dimensional (1D) GC will also have recognised differences, we will 
now be applying data interpretation methods to gauge and evaluate the relative advantages of having much 
greater separation for the matrix.
•	 The turnaround time for analysis of drug-capture samples depends upon the availability of suitable sampling 
equipment for automated SPME analysis (at present, we have used manual SPME). This will usually require 
a CombiPAL autosampler system. The GC×GC system requires about 40 minutes per sample; however, 
data analysis is a more time-consuming process.
•	 Note that for profiling, as opposed to simply measuring the presence of the active drug in a sample, this 
requires more substantial efforts on a chemometric method to compare and contrast samples against a 
library or database of samples analysed in the same manner. It is hoped that automated methods for such 
processing may become available in future arising from other work at RMIT, but this will probably need to be 
deferred to a future project.
Most recent work
In addition to the studies reported in mid-2009, the most recent work we have completed or proposed 
includes:
•	 the need to establish the long-term reproducibility of the GC×GC method for the different phase columns 
and geometries used in the experiment. An alternative will be to develop a metric for peak position 
correction in the 2D experiment based on a proposed standard or test mixture which is sensitive to changes 
in column properties with time. This will be important for concepts such as establishing a database of peak 
positions in GC×GC and for the process of retro-searching; and
•	 the study of WADA anabolic agents (AAs; Appendix reference 8) that are required for laboratories that seek 
WADA accreditation and re-accreditation purposes. This study established criteria for analysis of the AAs 
under conditions developed for GC×GC analysis. Specific observations are reported below:
Outcomes and further work
The work described in the papers (Refer to Appendix papers 1, 3, 6, 7) demonstrates that:
•	 A new mass spectrometry library must be generated in order to adequately match spectra from the time-
of-flight spectrometer. Conventional spectra in the NIST and related libraries are often based on quadrupole 
MS data, and in order to have a suitable match, in-house spectra need to be generated for authentic 
standard material. This is especially so for higher mass molecules, such as derivatised compounds.
•	 In order to optimise the process of cryotrapping, which is a thermal process, it was necessary to 
temperature program the cryotrap device as the oven temperature increases. This reduces consumption of 
CO2 cryogen. In essence, this produces efficient cooling for compound trapping, but does not excessively 
cool the column such that it retards the re-mobilisation process of the compound.
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•	 We developed a new metric for establishing the detection limits of a compound in GC analysis. This is 
termed Minimum Acceptable Matching (MAM), such that only a library match above the MAM is accepted 
as sufficient confirmation of the compound presence. This necessarily gives a detection limit that is higher 
than the conventional concept of 3 x S/N ratio. However, we feel that it is important to have correct 
confirmation of compound identity that recognises the use of a library matched statistic.
•	 We introduced the concept of a retro-searching capability for analysed samples, such that once a sample 
is analysed by the GC×GC technique, under conditions of full mass spectrometry data acquisition, it should 
be possible to subsequently identify steroids (or indeed any compound that is able to be analysed by GC) 
that are present in the sample but whose presence was neither anticipated nor known at the time. This will 
mean that a sample need not be re-analysed if, in future, a new designer drug was suspected or needed 
to be tested for in the sample. Once the gas chromatography (GC) and mass spectrometry (MS) properties 
of the new compound are established, previously collected data can be screened for the presence of these 
new target compounds. This will be a potentially invaluable deterrent for future use of illegal compounds in 
for example the sports competition arena.
Implications for law enforcement agencies with respect to 
GC×GC technologies
•	 Access to technologies, systems availability and cost
GC×GC and multidimensional GC (MDGC) are advanced operational methods for GC analysis. They 
are more expensive than single dimensional GC and GC/MS. If mass spectrometry detection is required 
for GC×GC, there are few options other than LECO Corporation who have an office in Sydney. This is, 
understandably, more expensive again. GC×GC-FID (flame ionisation detector) systems are also suitable 
for routine analysis, however, if identification of components is needed, mass spectrometry is mandatory. 
It is possible to have an analysis of a representative sample on a GC×GC/TOFMS system and translate 
this to FID analysis, and we have experience in this, but this requires access to a TOFMS system that is 
available for use. Our experience is that we always seek identification of peaks by re-analysis on GC×GC/
TOFMS. GC×GC/TOFMS may cost in the order of $200–250K. The many studies that are currently being 
investigated overseas (and in our RMIT labs) probably means that this is a technology of the future that 
eventually will become more of a mainstream technology and so forensic laboratories will have to adopt 
this eventually.
•	 Training of personnel
There is a major need for training of personnel for GC×GC analysis. We have much experience in training 
and have had in excess of 35 visiting overseas researchers in our laboratory in the past five years. They all 
come to study GC×GC and become somewhat expert after this time. We are prepared to undertake this 
training if required.
•	 Necessity of chemometrics
All GC analyses should require chemometrics in order to profile samples and seek underlying information. 
We show our preliminary chemometric studies herein and will be expanding our research in this in the 
future. The important ability to provide the links between samples and compare and contrast the key 
features of samples especially in the area of profiling is critical.
•	 Future collaboration
The opportunity to collaborate with leading researchers in Australia who have much experience in GC×GC 
and MS analysis will maximise the skills transfer and technical capabilities of GC×GC methodologies. This 
would be welcomed by this research group.
•	 Further research needs
There is a continuing need for research, since this project only touched on the opportunity for illicit 
drug profiling. This will require greater access to samples and close collaboration with law enforcement 
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agencies for background intelligence of samples. The focus here was on GC×GC, but MDGC needs 
to be also tested for advanced information on volatile chemical analysis. We have much experience in 
GC×GC and MDGC, and would suggest that the success of the present project would serve as a useful 
springboard for continuing research, again with closer collaboration.
Ongoing work
GCxGC analyses produce vast amounts of raw data that require chemometric interpretation to extract 
meaningful results. Software programs have been developed at RMIT to do this. They are currently being 
refined and optimised as part of other concurrent studies.
Conclusions and recommendations
The results presented in this final report indicate that there is considerable scope to be optimistic about the 
future for profiling of illicit drug samples by using GC×GC technology.
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Chapter One: 
Evaluation of World Anti-Doping Agency Criteria for 
Anabolic Agent Analysis by Using Comprehensive Two-
Dimensional Gas Chromatography Mass Spectrometry
Abstract
This work presents the validation study of comprehensive two-dimensional gas chromatography-time of flight 
mass spectrometry (GC×GC-TOFMS) method performance in analysis of the key WADA anabolic agents in 
doping control. The relative abundance ratio, retention time, identification and other method performance 
criteria have been tested in the GC×GC format to confirm if they comply with those set by WADA. 
Furthermore, tens of other components were identified with an average similarity of >920 (on the 0–999 
scale), including 10 other endogenous sterols and full mass spectra of 5,000+ compounds were retained. The 
testosterone/epitestosterone ratio was obtained from the same run.
A new dimension in doping analysis has been implemented by addressing separation improvement. Instead 
of increasing the method sensitivity that is accompanied by making the detector increasingly ‘blind’ to the 
matrix (as represented by selected ion monitoring mode, high-resolution mass spectrometry, tandem MS), the 
method capabilities have been improved by adding a new ‘separation’ dimension, while retaining full mass 
spectral scan information. Apart from the requirement for the mass spectral domain that a minimum of three 
diagnostic ions with relative abundance of five percent or higher in the MS spectra, all other WADA criteria 
are satisfied by GC×GC operation. The minimum of three diagnostic ions arises from the need to add some 
degree of specificity to the acquired mass spectrometry data; however, under the proposed full MS scan 
method, the high MS similarity to the reference compounds offers more than the required three diagnostic 
ions for an unambiguous identification. This should be viewed as an extension of the present criteria to a full 
scan MS method.
Introduction
Anabolic androgenic steroids (AAS) and β2-agonists with anabolic effect are the pharmacological substances 
most frequently abused in doping control. The International Olympic Committee and other organisations 
responsible for anti-doping control (ie WADA) have banned these substances because of their effect on 
athlete’s performance and consequently on the results of competitions.
The biological fluid of choice in current doping control methods is urine. Urine is a complex matrix containing 
many components in different concentrations and with similar structures, many of which are unknown. 
Anabolic agents are extracted from this matrix by solid phase extraction (SPE) (Buiarelli et al. 2001; Kokkonen 
et al. 1999; Schanzer & Donike 1993) or liquid/liquid extraction (L/LE) (Ayotte, Goudreault & Charlebois 1996; 
Geyer et al. 1998), conjugates are hydrolysed and the free agents are extracted again and derivatised into 
corresponding trimethylsilyl (TMS) derivatives. Beside this, many endogenous components are co-extracted 
to some extent and introduced in the chromatographic system. GC-MS is the preferred technique for analysis, 
because it offers high sensitivity and selectivity. However, the coelution of anabolic agents with endogenous 
components and the high background noise give rise to false signals in mass spectra and therefore it is 
possible to make erroneous interpretation (Munoz-Guerra et al. 1997). High resolution mass spectrometry 
(Horning & Schanzer 1997; Kokkonen et al. 1999; Schanzer et al. 1996; Thieme, Grosse & Mueller 1997) and 
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tandem mass spectrometry (Bowers & Borts 1996; Munoz-Guerra et al. 1997) have been proposed to solve 
this problem and to achieve ever lower limits of detection. Several approaches are proposed for increasing the 
sensitivity and selectivity of the methods by using an extra step in purification of the samples. In this manner, 
immunoaffinity chromatography (Machnik et al. 1997) and high performance liquid chromatography fractioning 
(Gotzmann, Geyer & Schanzer 1997) are employed. Recently, a new approach for separation improvement 
has been proposed by using GC×GC in sterol (Mitrevski et al. 2008, 2007; Silva et al. 2009, 2007) and drug 
analysis (Kueh et al. 2003). GC×GC is a relatively new technique that exhibits improved separation power 
compared with traditional 1D GC. The principles of GC×GC have been reported elsewhere (Adahchour et al. 
2006a, 2006b).
The applicability of GC×GC to doping analysis has been demonstrated previously (Mitrevski et al. 2008; Silva 
et al. 2009) through its improved separation and identification power when combined with time-of-flight mass 
spectrometry (TOFMS) as a detector. However, no evaluation of the method performance, as pertaining to 
assessment against specific WADA criteria has been presented so far. Therefore, herein a systematic and 
coherent evaluation of analysis of AAS against WADA criteria (World Anti-Doping Agency 2003) and a point-
by-point assessment of GC×GC/TOFSM related to each criterion is presented. The five key anabolic agents 
(clenbuterol, 19-norandrosterone, epimethendiol, methyltestosterone M2-metabolite and 3’OH-stanozolol) 
that WADA had listed at the low ng mL-1 level (World Anti-Doping Agency 2004) were used as model 
components.
Experimental
Reagents and chemicals
Clenbuterol, 19-norandrosterone, epimethendiol (EMD), 17a-methyl-5b-androstane-3a,17b-diol 
(methyltestosterone M2-metabolite), 3’OH-stanozolol and methyltestosterone (IS) were purchased from 
National Measurement Institute (Pymble, Australia). N-methyl-N-(trimethylsilyl)-trifluoroacetamide was 
purchased from Sigma Aldrich and β-glucuronidase (from E. Coli, K12) was supplied from Roche (Mannheim, 
Germany). All other reagents and chemicals were of analytical grade or higher. Water used in the experiments 
was of Milli-Q (Millipore) grade.
Sample preparation
Urine samples spiked with anabolic agents were prepared in the concentration range from 0.5 ng mL-1 to 20 ng 
mL-1 by adding an appropriate volume of the standard solutions and 25 µL of the internal standard solution (5 
µg mL-1) to the blank urine extracts. The extracts were prepared according to the previously published sample 
preparation procedure (Geyer et al. 1998; Saudan et al. 2006). Prior to analysis, the residue was derivatised by 
dissolving in 50 µL of derivatisation mixture (MSTFA-NH4I-ethanethiol, 1000:2:6) with heating at 80°C for 30 
minutes. Standard solutions of anabolic agents were prepared at a concentration of 0.5 µg mL-1 for the purpose 
of acquiring reference TOFMS spectra. Solutions were stored at 4°C when not in use.
Instrumentation
A Pegasus III time-of-flight mass spectrometer (LECO Corporation, St. Joseph, Michigan, United States) 
connected to an Agilent 6890 gas chromatograph fitted with a Longitudinal Modulation Cryogenic System 
(LMCS) (Chromatographic Concepts Pty Ltd, Victoria, Australia) was used in GC×GC-TOFMS experiments. 
The detector was operated at 1600V and applied electron ionization voltage was 70eV. Data acquisition rate 
was 100Hz over the mass range from 45amu to 600amu. Data acquisition and processing were performed by 
ChromaTOF software (LECO Corporation, St. Joseph, Michigan, United States). A separate GC×GC-TOFMS 
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based in-house library for improved identification was generated using standard solutions of anabolic agents 
at a concentration of 0.5 µg mL-1. The NIST algorithm was used for mass spectra searching.
The column configuration applied was non-polar/polar consisting of 30 m BPX5 (0.25 mm I.D.; 0.25 µm df) as 
a ID column and 1 m BPX50 (0.1 mm I.D.; 0.2 µm df) as a 2D column. The oven temperature program was 
from 120°C (hold for 1 minute) to 320°C (hold for 5 minutes) at 4°C min-1, at a flow rate (He) of 1.3 mL min-1. 
1 µL samples were injected in splitless mode (2.5 minute purge time).
Results and discussion
Retention time tolerance criteria
Present WADA criterion:
The retention time of the analyte shall not differ by more than 1% or ±0.2 minutes (whichever is 
smaller) from that of the same substance in a spiked urine sample or reference material analysed 
contemporaneously (World Anti-Doping Agency 2003, page 1).
The relative standard deviation (RSD) of the first dimension (1tR) and second dimension (2tR) retention times 
of the proposed method has been calculated from a series of spiked urine samples with anabolic agents 
at different levels of concentration and the results are given in Table 1.1. A representative 2D plot of urine 
extract spiked with sterols at a concentration of 10 ng mL-1 is given in Figure 1.1. The reproducibility (%RSD) 
of 1tR has been found to range from zero percent for clenbuterol-2TMS and 19-norandrosterone-2TMS to 
0.18 percent for EMD-2TMS, which agrees with the previous findings for GC×GC reproducibility (Shellie, 
Xie & Marriott 2002). The relative error of the retention times of the reference compounds are well within the 
tolerance window of one percent (World Anti-Doping Agency 2003). The lowest deviation (see Table 1.1) has 
been obtained for clenbuterol-2TMS and 19-norandrosterone-2TMS (0%) and the highest for EMD-2TMS 
(0.23%). The zero percent RSD values for clenbuterol-2TMS and 19-norandrosterone-2TMS are due to the 
‘quantised’ values of the 1tR values derived from the modulation process and data processing software. 
Specifically, ChromaTOF assigns the same 1tR for all components in the same modulation period, regardless 
of their 2tR values. In addition, since each component generates more than one modulation peak, the 1tR 
of the component is assigned the retention time of the highest modulated peak. Obviously, the highest 
modulated peak for clenbuterol-2TMS has been found in the same modulation event at 1670 s in each run, 
and likewise for the 19-norandrosterone-2TMS peak at 2125 s to give an ‘arbitrary’ 1tR variation evaluated 
to be zero percent. Therefore, it is not necessarily true that each replicate of each of these compounds has 
exactly the same 1tR, but rather is an artefact of the data presentation. This group has proposed an algorithm 
for exact 1tR determination in GC×GC (Adcock et al. 2009).
Table 1.1 1tR and 2tR retention times reproducibility and the relative error to the reference compounds
clenbuterol-2TMS 19-norandrosterone-
2TMS
EMD-2TMS M2-2TMS
metabolite
3’OH-stanozolol-
3TMS
1tR (s) 2tR (s) 1tR (s) 2tR (s) 1tR (s) 2tR (s) 1tR (s) 2tR (s) 1tR (s) 2tR (s)
AAS 
average 
(n=13)
1670 2.498 2125 2.577 2170 2.627 2343 3.071 2918 3.075
RSD (%) 0.00 0.65 0.00 0.75 0.18 0.83 0.10 0.64 0.09 0.57
ref. 
average 
(n=2)
1670 2.480 2125 2.565 2165 2.605 2340 3.045 2920 3.055
rel. error 
(%)
0.00 0.72 0.00 0.47 0.23 0.84 0.13 0.85 0.07 0.65
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Figure 1.1 2D plot of urine extract spiked with anabolic agents at a concentration of 10 ng mL-1
Note: The 2tR is shifted vertically by -1 (s) to provide a better presentation format
The 2tR relative error of the reference compounds, even though not defined as part of the established WADA 
criteria, fall within the tolerance window of one percent. The reproducibility is in agreement with the previous 
results (Shellie, Xie & Marriott 2002) and the relative error is from 0.47 percent (for 19-norandrosterone-2TMS) 
to 0.85 percent (for M2-2TMS metabolite). Reproducibility in 2tR values is found to depend on maintaining 
constant CO2 cryogen supply, since the temperature of the modulator can influence the 2tR; clearly the 
values found here, being less than one percent RSD, are acceptable for purposes of this criterion. The high 
reproducibility of 1tR produces very reproducible elution temperature for all anabolic agents, which in turn 
means constant and stable 2tR. If the modulation process is properly conducted, the 2tR is very robust 
so the same criteria (1% relative error) can be applied also for this additional parameter. We stress that the 
retention time reproducibility was carried out on spiked urine samples at different concentration levels over 
the range from the limit of detection (2 ng mL-1) to the highest tested concentration level (20 ng mL-1), 
which demonstrates a rugged reproducibility assessment of 1tR. In the event that WADA adopts GC×GC 
technology, then a new criterion specific for 2tR will need to be considered.
Relative abundance tolerance window criteria
Present WADA criteria:
All diagnostic ions with relative abundance greater than 10% in the reference spectrum must be present in the 
spectrum of the unknown peak, and
The relative abundance of three diagnostic ions shall not differ by more than the amount shown in Table 
1.2 from the relative intensities of the same ions from that of a spiked urine or reference material (World 
Anti-Doping Agency 2003, page 2)
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Table 1.2 Maximum tolerance windows for relative ion intensities to ensure appropriate uncertainty in 
identification
Rel. abundance
(% of base peak)
EI-GC/MS
>50% ± 10% (absolute)
25% to 50% ± 20% (relative)
<25 ± 5% (absolute)
Source: World Anti-Doping Agency 2003
The mass spectrometric detection and identification in selected ion monitoring (SIM) mode is usually based on 
monitoring of one quantification ion (for estimation of concentration) and two or more qualification ions (qualifiers, 
for identification criteria). The relative abundance of these diagnostic ions in unknown samples compared 
with the relative abundances of the same ions from the reference compounds is used as criteria for positive 
identification. The graphical view of the maximum tolerance window of relative difference against the relative 
abundance of the ions, based on WADA criteria (World Anti-Doping Agency 2003), is given in Figure 1.2.
Several diagnostic ions and ion ratios for each anabolic agent have been tested against their compliance with 
the WADA relative abundance criteria. The results are summarised in Table 1.3.
Figure 1.2 Graphical view of the maximum tolerance window of the relative difference against the m/z 
abundance, according to the WADA criteria
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Table 1.3 Relative abundance of diagnostic ions and their combinations
Clenbuterol-2TMS
(n=12)
ion (m/z) 86 335 337 335/86 337/86 337/335
average (%) 65.7 10.2 8.2 12.2 9.0 74.6
STD 27.1 3.1 2.3 0.6 0.6 2.6
out of 
rangea
8 - - - - -
19-norandrosterone-
2TMS
(n=11)
ion (m/z) 405 420 315 420/405 315/405 315/420
average (%) 35.4 14.9 13.4 41.9 36.6 81.0
STD 20.4 9.7 8.7 3.5 5.1 13.5
out of 
rangea
8 6 4 - 1 2
EMD-2TMS
(n=12)
ion (m/z) 358 143 216 358/143 216/143 358/216
average (%) 1.9 67.1 3.4 2.9 5.0 57.6
STD 0.3 9.0 0.7 0.4 0.7 9.0
out of 
rangea
- 4 - - - 1
M2-2TMS 
metabolite
(n=10)
ion (m/z) 255 143 435 255/143 435/143 255/435
average (%) 2.7 86.9 2.8 3.3 3.5 94.7
STD 0.4 19.0 1.3 0.4 1.3 29
out of 
rangea
- 4 - - - 3
3’OH-stanozolol-
3TMS
(n=9)
ion (m/z) 254 143 545 254/143 545/143 545/254
average (%) 15.1 51.6 6.1 29.5 12.7 44.6
STD 6.5 23.3 2.8 3.1 3.3 12.9
out of 
rangea
1 6 1 1 - 1
a Number of spiked urine samples (out of the total number of analysed samples) that do not comply with the WADA relative abundance criteria
The results in Table 1.3 demonstrate that all ions and ion combinations for clenbuterol-2TMS, except for 
86m/z alone, comply with the WADA criteria. The low reproducibility of the relative abundance of 86m/z is due 
to two main factors:
•	 The low uniqueness of the base ion 73m/z in TOFMS spectra. This ion is present in all TMS derivatised 
compounds—endogenous or exogenous—since it is a fragment pertaining to derivatising agent. In 
contrast, the base ion in quadrupole-based MS spectra (NIST05) is 86m/z, which is more characteristic 
than 73m/z.
•	 The narrower permitted tolerance window of the relative difference for ions with higher relative abundance 
(see Figure 1.2).
However, 335m/z, 337m/z and their combinations, including the combinations with 86m/z, have complied 
with the criteria. The relative abundance ratio has shown higher reproducibility than the relative abundances 
itself. All ion combinations fell well within the tolerance window.
The relative abundance of the diagnostic ions and their combinations for EMD-2TMS fell within the tolerance 
window, except the 143m/z ion. Again, the main reasons for this are the same as for clenbuterol-2TMS—the 
low uniqueness of 73m/z as a base ion in TOFMS spectra of EMD-2TMS and the narrower tolerance window 
for ions with higher abundances. Any tested combination, except 143m/z alone, can be used as a qualifier.
Methyltestosterone metabolite M2-2TMS gives similar results to EMD-2TMS. 143m/z alone cannot be used 
as a diagnostic ion since it shows low reproducibility and does not comply with the established identification 
criteria. Another combination which cannot be used is the relative ratio of the 255m/z and 435m/z relative 
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abundance; because they are both of low abundance (less than 3% of the base ion), their ratio can therefore 
vary greatly. All other ions and ion combinations (255m/z, 435m/z, 255/143m/z and 435/143m/z) can be used 
as qualifiers.
The 143m/z ion alone, as well as 254m/z alone, did not pass the test as qualifiers for 3’OH-stanozolol-3TMS. 
However, 545m/z, 545/143m/z and 254/143m/z gave results within the tolerance window. 560m/z cannot 
be used as a diagnostic ion in samples with a concentration of 3’OH-stanozolol-3TMS lower than 4ng mL-1, 
because of the observed bias of TOFMS towards higher masses (Mitrevski, Wilairat & Marriott 2010a). The 
comparison of TOFMS and quadrupole MS spectra of 3’OH-stanozolol-3TMS is given in Figure 1.3. The relative 
abundance of 560m/z in TOFMS spectrum of 3’OH-stanozolol-3TMS acquired at 0.5µg mL-1 concentration in 
standard solution (see Figure 1.3a) shows approximately 20 times lower relative abundance when compared to 
the quadrupole based MS spectra (see Figure 1.3b) (Huenerbein et al. 2003; Schanzer et al. 1996). However, the 
TOF mass spectra similarity of 3’OH-stanozolol-3TMS to the in-house created TOFMS library ensures positive 
identification of this sterol even at the lowest level of concentration spiked in urine extracts.
Figure 1.3 Comparison of (a) TOFMS spectra of 3’OH-stanozolol-3TMS acquired at 0.5 µg mL-1 in standard 
solutions and (b) its entry from the NIST05 MS database. Note that the abundance of several consecutive 
mass intervals in TOFMS spectrum is enhanced by factors given above the intervals
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Each of the diagnostic ions alone for 19-norandrosterone-2TMS (405m/z, 420m/z and 315m/z) have failed 
the criteria despite the good similarity of TOFMS spectra to the entries in the in-house library. One of the 
reasons could be the coelution of 19-norandrosterone-2TMS with the endogenous component which shares 
some of the diagnostic ions (Mitrevski, Wilairat & Marriott 2010a), but most probably the reasons are the 
same as for the other anabolic agents. However, their combinations (with few exceptions at the lower levels 
of concentration) gave results within the tolerance window (see Table 1.2). Furthermore, the spectral similarity 
even at the lowest level of concentration is high enough to ensure unambiguous identification. The similarity 
of 19-norandrosterone-2TMS spiked in urine extract at different concentrations is given in Table 1.4. The 
general trend of increased similarity for higher concentrations has been observed, even though the variation of 
similarity has been found to be quite large (within ±10%).
The lower relative abundance of higher masses observed in TOFMS spectra of anabolic agents can be seen 
as an advantage over GC-qMS identification since the maximum tolerance window of the relative difference 
for lower abundance diagnostic ions is wider (see Figure 1.2) and the reproducibility of TOFMS spectra even 
at the lowest levels of concentration is good. Conversely, the diagnostic ion ratio, which is not implemented in 
the WADA criteria, gave reproducible and consistent results, allowing this to be used as a criterion in anabolic 
agent identification.
Table 1.4 TOFMS similarity of 19-norandrosterone-2TMS spiked in urine extracts at different levels of 
concentration against the in-house TOFMS library
conc. level (ng mL-1) similarity (n=2)
500 (std sol.) 945
20 926
10 867
8 891
6 888
4 799
2 784
Other criteria
Presence of diagnostic ions
Present WADA criteria:
Diagnostic ion with relative abundance of less than 5% in the reference must be present in the unknown 
(World Anti-Doping Agency 2003, page 1)
All the diagnostic ions with abundance above 10 percent that were present in the reference spectra of the 
anabolic agents have been detected also in the spiked urine samples. When ions with abundance lower 
than five percent were chosen as the qualifier, these ions were also detected in spiked samples, even at the 
lowest concentration tested. As stated previously, the commonly used 560m/z ion for 3’OH-stanozolol-3TMS 
was not chosen as a qualifier because of the decreased sensitivity of TOFMS at higher masses. Figure 1.3 
shows the comparison of TOFMS spectra of 3’OH-stanozolol-3TMS and its entry in NIST05 MS database 
(qMS based spectrum). For the same reason the ion 448m/z is not considered in EMD-2TMS identification 
criteria. This creates the biggest challenge in strictly applying the WADA criteria in GC×GC-TOFMS—the lack 
of three diagnostic ions with abundance above five percent. As can be seen from Table 1.2, the abundances 
of 358m/z and 216m/z for EMD-2TMS, and 255m/z and 435m/z for M2-2TMS metabolite, are below five 
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percent. As a comparison, the abundance of these ions in NIST05 library entries of the same sterols is 
between 10 percent (216m/z) and 30 percent (435m/z). However, the high similarity of TOFMS spectra from 
spiked urine samples to the TOFMS spectra of the reference compounds permits unambiguous identification 
based on all ions in the spectrum. This has a range of ramifications for establishing a new criterion based 
on adequacy of library matches to sterol spectra as opposed to simply comparing ion ratios in SIM spectra 
(Mitrevski et al. 2008).
Isotope ratio criteria
Present WADA criteria:
A second ion belonging to the same isotopic cluster may also be used as diagnostic only when the 
peculiarity of the atomic composition of the fragment so justifies (e.g. presence of Cl, Br, or other 
elements with abundant isotopic ions) (World Anti-Doping Agency 2003, page 4)
The clenbuterol molecule contains two chlorine atoms and its isotope pattern can be another useful criterion 
in identification of this anabolic agent. The ion abundance ratios of 337/335m/z and 339/335m/z have been 
compared against the theoretical values calculated by the isotope calculator from the NIST MS Search 
software package (version 2.0). The average ion abundance ratios were calculated from 12 spiked urine 
samples with anabolic agents over the concentration range from 2ng mL-1 to 20ng mL-1. The results are 
given in Table 1.5.
Table 1.5 Experimental and calculated isotope ratio patterns for clenbuterol-2TMS
ion abundance ratio area ratio
337/335m/z 339/335m/z 337/335m/z 339/335m/z
average (%)
(n=12)
74.6 17.8 76.5 21.1
RSD (%) 3.4 11.7 2.6 11.8
calculated (%) 73.7 16.7 - -
Good agreement has been obtained between the experimental and the calculated values for both ion ratios—
337/335m/z and 339/335m/z (see Table 1.5). The 337/335m/z and 339/335m/z ratios, when the peak area 
was used instead of ion abundances, were slightly higher. However, the reproducibility of the 337/335m/z ion 
abundance and area ratio was better than the 339/335m/z ratios.
The good agreement between the experimental results obtained from clenbuterol-2TMS spiked at different 
concentration in urine extract to the theoretical values is a result of the deconvolution capabilities of the 
ChromaTOF software. The high acquisition rate (100Hz) contributes to the correct deconvolution. A series of 
deconvoluted MS spectra of clenbuterol-2TMS spiked in urine extract at different concentrations, showing the 
chlorine isotope pattern, are given in Figure 1.4.
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Figure 1.4 Deconvoluted TOFMS spectra of clenbuterol-2TMS spiked in urine extracts at different 
concentrations, expanded over the 334–339m/z cluster and normalized to 335m/z as the base ion
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Furthermore, the appearance of 334m/z in the experimental results (but not in the calculated isotope pattern) 
and the differences arising in the isotope pattern at 336m/z and 338m/z between experimental and calculated 
results (see Figure 1.5) may be explained by presuming the formation of a species with A-1m/z (ie the 334m/z 
ion). The isotope pattern of the dominant fragment ion at m/z 335 is shown in Figure 1.5. The experimental 
spectrum in this region extends from 334–341m/z. Note that ion 334m/z will not arise from fragment mass 
loss from the parent ion, but arises from an A-1 ion species. Taking the predicted isotope pattern for the 
335 ion, including the Cl isotopes, gives the pattern labelled as ‘calculated without A-1 ion’. This is a very 
poor match with the experimental pattern. In order to calculate the isotope pattern correctly, we invoke 
the presence of the A-1 ion, and since it contains 2 x Cl atoms, it will have a strong isotope contribution at 
336m/z. This leads to the large discrepancy between the experimental pattern and the calculated pattern in 
the absence of the A-1 species. Once the A-1 species is included as an overlapping ion pattern, very good 
agreement between experimental and calculated patterns arises.
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Figure 1.5 Cluster isotope pattern of clenbuterol-2TMS in standard solution at 0.5µg mL-1 for experimental 
data, calculated data (by assuming the A-1 fragment has been formed in a ratio 1:2 against A), and 
calculated data without taking the A-1 fragment formation into account
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Linearity
The linearity of the proposed method has been calculated from spiked urine extracts with anabolic 
agents at different concentrations from 0.5ng mL-1 to 20ng mL-1. The correlation coefficients and the 
linearity curve equations are given in Table 1.6. The highest correlation was obtained for EMD-2TMS and 
19-norandrosterone-2TMS (0.996) and the lowest for M2-2TMS metabolite (0.992). Please note than even 
the AA’s quantification ions are detected down to the lowest tested concentration (except for EMD-2TMS 
at 0.5ng/mL), unambiguous identification is obtained only at 1ng/mL and above for clenbuterol-2TMS, 
19-norandrosterone and M2-2TMS, and at 2ng/mL and above for EMD-2TMS and 3’OH-stanozolol-
3TMS (Mitrevski, Wilairat & Marriott 2010a). The good correlation coefficients are the result of the temporal 
deconvolution of the anabolic agents’ mass spectra from the background components and this is a direct 
result of the separation of the components in the two-dimensional space. The high acquisition rate of the 
TOFMS detector (100Hz) further facilitates the deconvolution in the mass spectral domain. As we have 
previously shown (Mitrevski, Wilairat & Marriott 2010b), the poorer separation of the components on the 
0.1µm df 2D column gave lower similarity which is based on the poorer deconvolution. Furthermore, the low 
acquisition rate of the TOFMS detector (20Hz) in 1D GC experiments and the separation based on classical 
1D GC gave even lower mass spectra similarity against TOFMS entries in the in-house library.
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Table 1.6 Linearity parameters for the anabolic agents spiked in urine extracts at different concentrations 
from 0.5ng mL-1 to 20ng mL-1
anabolic agent quant. ion linearity equationa correlation coefficient
epimethendiol-2TMS 358m/z Y=0.0081x + 0.0074 0.996
19-norandrosterone-2TMS 405m/z Y=0.0061x + 0.0094 0.996
M2-2TMS metabolite 255m/z Y=0.0144x + 0.0070 0.992
clenbuterol-2TMS 335m/z Y=0.0143x + 0.0050 0.994
3’OH-stanozolol-3TMS 254m/z Y=0.0043x + 0.0003 0.994
a: Y=Area(AAS) / Area(IS); x=concentration of AAS (ng mL-1)
Testosterone/epitestosterone ratio
Testosterone/epitestosterone ratio values can be calculated from the same run with unambiguous 
identification of both sterols. The average similarity of testosterone and epitestosterone TOFMS spectra 
against the in-house library, across the concentration range of AAS from 0.5ng mL-1 to 20ng mL-1 in urine 
samples, was 915 and 820, respectively.
Signal-to-noise ratio
Present WADA criteria:
The signal-to-noise ratio of the least intense diagnostic ion must be greater than 3:1 (World Anti-Doping 
Agency 2003, page 3)
The final criterion that must be complied with is the signal-to-noise (S/N) ratio for the least intense diagnostic 
ions. The lowest S/N permitted in WADA criteria is 3:1. S/N ratio for quantification ions obtained at 0.1µg 
mL-1 in standard solution (corresponding to 2ng mL-1 in spiked urine samples at a concentration factor of 50 
has been found to be above 18 (Mitrevski, Wilairat & Marriott 2010a). The lowest S/N (4) has been obtained 
for EMD-2TMS (358m/z) spiked in urine extracts at 2ng mL-1. This is again due to the bias of TOFMS towards 
the higher masses, combined with the low relative abundance of 358m/z. The lack of potential diagnostic ions 
in the TOFMS spectra of EMD-2TMS limits the choice.
19-norandrosterone-2TMS and 3’OH-stanozolol-3TMS are the only anabolic agents which completely comply 
with defined WADA criteria, since all others do not contain at least three diagnostic ions with abundance 
higher than five percent relative to the base ion. However, WADA permits a laboratory to establish its own 
identification criteria which can be based on minimum MS similarity against the reference compounds. A 
minimum acceptable match has been defined (Mitrevski et al. 2008) as a criteria for identification of minor 
components in a complex matrices such as urine, where a library match is required to be above a certain 
match quality in order to provide satisfactory identification of the component. The minimum acceptable match 
in doping control depends on the reproducibility of the MS similarity and probably is best to be set at the 
average MS similarity of anabolic agents at the positive urine control level, corrected for the standard deviation 
of the reproducibility. We have found that for unambiguous identification, the minimum acceptable match 
can be set at 800 when analysing free sterols in non-hydrolyzed urine samples (Mitrevski et al. 2008) and to 
700 in hydrolysed urine samples (Mitrevski, Wilairat & Marriott 2010b). The main reason is the more complex 
urine extract from hydrolysed samples. Obviously, MS similarity is just a confirmation of the other identification 
parameters, such as relative abundance ratio and retention time tolerance windows. In this case, the minimum 
acceptable match serves the purpose of providing a minimum value for the quality of full mass spectral 
similarity matching against, here, the in-house library for sterols. By all measures, this should represent a 
sound basis for confirmation (subject to the metric by which library searches are performed). The compounds 
can still be quantified based on a selected single quantification ion if so desired.
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Other benefits of the GC×GC-TOFMS method
Among testosterone and epitestosterone, another eight sterols which were investigated in our previous work 
(Mitrevski et al. 2008) were detected in the urine extract with an average similarity above 900. Once full MS 
data are available, the presence of sterols can be confirmed in post-run processing, allowing retro-searching 
for newly designed sterols, should the analyst become aware of such sterols or any other illicit compounds in 
the future.
Another advantage of having access to the full mass spectral information is characterisation of the interfering 
components and the matrix. Just as the deconvolution works for the target anabolic sterols, so it works also 
for matrix components and their spectra are likewise deconvoluted. This is a simple and inexpensive way to 
characterise trace components in urine matrix by their full deconvoluted mass spectra and not just a limited 
suite of sterols defined by selected SIM ions and retention windows.
Finally, as previously stated, several tens of other non-target components were identified with high similarity. 
Most of them are low molecular mass components because lower mass components have higher similarity 
against the NIST05 database than their high mass counterparts. At present, we have only chosen sterols 
to be in our custom in-house library. A dedicated comprehensive TOFMS library is needed for proper 
identification of higher molecular mass components because of the previously stated bias of TOFMS against 
the higher masses and consequent larger differences between qMS (used for most library entries) and TOFMS 
spectra.
Conclusion
The results presented here confirm that GC×GC-TOFMS of anabolic agents largely complies with the 
established WADA identification criteria. This technique has been shown to be a powerful tool for detection 
and unambiguous identification of trace amounts of anabolic agents in complex matrix as urine, so proved to 
be a promising choice for doping control in sport competition.
Retention time reproducibility on both columns has been found to be below 0.83 percent, allowing relative 
error to the reference components to be within the WADA tolerance window of one percent. The second 
dimension retention time relative error also complies with these criteria, although it is not explicitly required in 
the WADA criteria.
The relative abundance tolerance criteria have been complied with by most of the diagnostic ions selected, 
except for the high abundance ions or the ratio between two low abundance ions. Spectral deconvolution 
has been demonstrated in the case of clenbuterol-2TMS, where very good agreement has been obtained 
between experimental and theoretical calculations for the isotope cluster from 334–339m/z.
Other general criteria complied with include the linearity and minimum spectral match quality for positive 
identification. The deconvoluted full mass spectral information of the non-target components and the matrix 
are other benefits from this method. The least-complied criterion of the proposed method is the presence of 
at least three diagnostic ions in the TOFMS spectra with abundance above five percent of the base peak. This 
appears to be due to the predominance of the 73m/z in sterol spectra and if scans were to exclude the 73m/z 
ion by presenting data at >73m/z, then the WADA criteria may be complied with. Because of the observed 
bias towards the higher masses, only 19-norandrosterone-2TMS and 3’OH-stanozolol-3TMS comply with the 
criteria. However, the high similarity based on the full mass spectra offers an unambiguous identification even 
at the lowest tested concentrations. This latter benefit of using full scan TOFMS data is not available for most 
classical methods used in doping control that rely on SIM analysis.
The present work suggests that the GC×GC/TOFMS method can play an important role in doping control 
and drug testing in the future. Separation of components on 2D space relaxes the eventually co-elutions with 
the matrix components and deconvoluted full mass TOFMS spectra offers unambiguous identification. This 
makes the method a good alternative for anti-doping screening and if sensitivity is improved and confirmed 
when recovery is taken into consideration, the method can be a promising option for AAS confirmation.
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Chapter Two: 
Organic Impurity Profiling of Ecstasy Tablets by Using 
Comprehensive Two-Dimensional Gas Chromatography
Introduction
Amphetamines are the second most commonly used illicit drug type in Australia, after cannabis (McKetin & 
McLaren 2004). Ecstasy, a term referring to tablets containing 3,4-methylenedioxy-methamphetamine (MDMA) 
as an active component, are very popular among young party goers for their short-term effects, which include 
a heightened sense of wellbeing, reduced inhibitions, increased energy levels and self-confidence. According 
to the World Drug Report 2008 (UNODC 2008), at 4.4 percent Australia has the highest rate of ecstasy users 
in the world for those aged 15–64 years. The composition of these illicit preparations can vary significantly 
under the influence of synthetic route, purification methods, source materials and the presence of cutting 
agents and tabletting excipients. As clandestine laboratories rarely adopt good manufacturing practices or 
standard preparation procedures, the presence and relative concentrations of trace impurities and additives 
may serve as chemical ‘fingerprints’ that are unique to a particular manufacturer, ‘cook’ or batch of drugs.
In the last two decades, considerable international effort has been made in the fight against illicit production 
and distribution of amphetamine-type stimulants, including ecstasy. In addition to cataloguing the physical 
characteristics (colour, shape, logo, dimension and mass) of seized samples (Marquis et al. 2008; Milliet, 
Weyermann & Esseiva 2009), other chemical features including the presence of major components, trace 
organics (Kongshaug et al. 1999; Milliet, Weyermann & Esseiva 2009; Weyermann et al. 2008; van Deursen, 
Lock & Poortman-Van Der Meer 2006), metals (Koper et al. 2007; Waddell, NicDaeid & Littlejohn 2004) 
and the isotopic ratio of 15N/14N (Buchanan et al. 2008; Carter et al. 2002; Collins et al. 2007; Mas et al. 
1995; Palhol et al. 2004; Palhol, Lamoureux & Naulet 2003) have been profiled. Several laboratories have 
harmonised their methods of analysis in the interests of efficient data sharing across jurisdictions (Collins et al. 
2007; van Deursen, Lock & Poortman-Van Der Meer 2006).
Impurity profiling is understood to be the chemical analysis, collection of data and its use for evidential or 
intelligence purposes (Collins et al. 2007; Esseiva et al. 2007; Huizer 1994; van Deursen, Lock & Poortman-
Van Der Meer 2006); the more information that is gathered during the analytical phase, the greater the 
opportunity to derive some useful information from the relationship between the seized specimen and the 
database (Collins et al. 2007). Trace organic component analysis is most often used for profiling or developing 
a sample ‘signature’ because it has the capacity to provide higher information content than other forms of 
analysis.
Many reported methods for organic impurity analysis involve L/LE (Gimeno et al. 2002; Milliet, Weyermann & 
Esseiva 2009; Weyermann et al. 2008; van Deursen, Lock & Poortman-Van Der Meer 2006) and subsequent 
analysis by gas chromatography coupled to a GC-FID (Kongshaug et al. 1999; Mitrevski & Zdravkovski 2005) 
or GC-MS (Bonadio et al. 2008; Gimeno et al. 2002; van Deursen, Lock & Poortman-Van Der Meer 2006). 
Solid phase micro extraction (SPME) of volatile components (Bonadio et al. 2009, 2008) in ecstasy samples 
was found to give comparable results to L/LE for the detection of the most discriminative components. SPME 
was reported to be a simpler, faster and to reduce the sources of error.
Chemical ‘signatures’ have been interpreted and reported in a variety of ways. Principal component analysis 
(PCA) (Palhol et al. 2004; Weyermann et al. 2008) and hierarchical cluster analysis (HCA) (Buchanan et 
al. 2008; Koper et al. 2007; Palhol et al. 2004; Waddell, NicDaeid & Littlejohn 2004) have been used for 
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classifying samples according their similarities (intelligence), while Pearson correlation coefficients (Bonadio 
2009, 2008; Milliet, Weyermann & Esseiva 2009; Weyermann et al. 2008; van Deursen, Lock & Poortman-Van 
Der Meer 2006) and cosine functions (Gimeno et al. 2002; Weyermann et al. 2008) have been employed for 
differential comparisons or evidential purposes. Most of the reported drug profiling methods have used single-
column (or 1D) chromatographic techniques. The large number of trace components found in the many illicit 
drug samples results in 1D chromatographic methods have insufficient separating power to map important 
regions in the chromatogram. Co-elution masks the presence of trace impurities that are definitive to the 
chemical signature and reduces the informing power of the analysis. While MS can be used for deconvolution 
of co-eluting peaks, this method is only useful where there is either sufficient mass spectral power or where 
the components are well resolved in the mass domain. In most cases, resolution to evidential standard relies 
on either a reduction in the informing power of the mass spectrum or the application of a tandem technique.
Multidimensional chromatographic technologies provide a facile means of achieving high separation 
efficiency with a single injection in acceptable analysis times. Neumann and Meyer (1987) used ‘heart-cut’ 
multidimensional GC for the analysis of illicit heroin. Thus, two GC columns of highly different selectivity were 
connected by a pneumatic Deans switch at the confluence of the two columns. The switching device directs 
specific (co-eluting) bands from the first column (1D) to the second column (2D) for further analysis. This 
approach is particularly useful when specific regions of a 1D chromatogram contain severely overlapping 
analytes. The different selectivity of the 2D GC column affords enhanced resolution power to reveal trace 
impurities, which might otherwise be obscured.
In comprehensive GC×GC, rather than sampling subsections of the 1D column chromatogram, the entire 
eluted volume from the first column is subjected to further analysis on the 2D column. Maximising the 
separating power of the two-column set is reliant on selecting phases that have orthogonality selectivity 
towards the analytes of interest and so it is to be expected that column sets will be tuned to particular tasks. 
The 2D column in GC×GC must act as a fast-eluting high-efficiency column and is typically 0.5–2m in length 
and 0.1mm I.D. with a 0.1µm film thickness (df). The interface between the two columns (modulator) has to 
trap/accumulate all the components which elute from the 1D column for a predefined period (typically 3–8 
s) and then release the ‘focused’ band in narrow fractions to the 2D column. The efficient trapping and fast 
release of components is usually achieved by cryo-focusing, which yields ultra-narrow peak widths at the end 
of the 2D column.
GC×GC has been successfully applied in the analysis of petrochemical (Adahchour et al. 2004; Beens, 
Blomberg & Schoenmakers 2000), food (Adahchour et al. 2004; Khummueng et al. 2006), environmental 
(Focant, Sjodin & Patterson 2004), forensic (Frysinger & Gaines 2002; Groger et al. 2008; Kueh et al. 2003; 
Song et al. 2004; Song 2006), doping (Mitrevski  et al. 2008; Silva et al. 2009) and essential oil (Junge et al. 
2007; Shellie, Marriott & Morrison 2001) samples in complex matrices. In addition to improved peak capacity, 
GC×GC yielded highly structured chromatograms and improved sensitivity from increased signal height when 
compared to classical GC (Mitrevski et al. 2008, 2007).
Although GC is an important technique for amphetamine-type stimulant profiling, to the authors’ knowledge, 
no reports have been made describing the application of GC×GC in this area. GC×GC has characteristics that 
make it ideally suited for drug profiling purposes (Barnfield et al. 1988). In the present paper, we describe the 
chemical profiling of 24 ecstasy tablets by GC×GC from multiple jurisdictions and describe its potential as a 
new chemical profiling tool.
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Materials and methods
Samples
Twenty-four ecstasy tablets in total were used in the experiments, of which nine were seized in Macedonia 
(2006–07) and provided by Macedonian Police, and 15 were seized in Australia (2009) and provided by 
Australian Federal Police. Macedonian samples were from nine different seizures, but were classified into 
three groups of three tablets according to their post-tabletting (post-TB) physical characteristics (logo, colour, 
diameter and thickness) and intelligence information. The Australian samples were from one recent seizure 
and were classified into five groups of three tablets according to their physical characteristics (post-TB).
Sample preparation
MDMA tablets were quickly crushed and homogenised by using mortar and pestle. A 20mg portion of the 
fine powder was placed in a 4mL septum-sealed vial. After 30 minutes equilibration of the sample at 80°C, a 
65µm polydimethylsiloxane/divinylbenzene SPME fibre (Supelco, Belafonte, United States) was inserted and 
exposed to the headspace for another 30 minutes. The samples were desorbed in the GC injection port for 
five minutes at 250°C.
Instrumentation
An Agilent 7890 GC was used in GC-accurate time-of-flight mass spectrometry (GC-accTOFMS) and flame 
photometric detection experiments and an Agilent 6890 GC fitted with a LMCS modulator (Chromatography 
Concepts, Doncaster, Victoria, Australia) was used in all other 1D GC and GC×GC experiments. A LECO 
Pegasus III MS instrument was used in fast acquisition TOFMS (fastTOFMS) experiments, an Agilent 5973 
MSD in quadrupole MS (qMS) and Waters GCT Premier in accTOFMS experiments. 1D experiments were 
carried out either on a single column (qMS and accTOFMS) or under the same conditions as in GC×GC, 
except the modulator was off and the acquisition rate of fastTOFMS detector was reduced to 20Hz. 
Therefore, in this case, the 1D system comprised a long column directly coupled to a short column. While 
this can be termed a multi-chromatography system according to Hinshaw and Ettre (1986) and discussed 
elsewhere (Marriott & Kinghorn 2000), the second very short column is anticipated to lead to negligible 
variation in peak properties such as width.
The GC conditions were kept the same for each column configuration, except column head pressure which 
depends on the column dimensions. Column sets used are listed in Table 2.1. Columns denoted BP were 
from SGE Analytical Science (Ringwood, Victoria, Australia) and the HP column was from Agilent (Folsom, 
California, United States). Conditions are given below, unless otherwise specified. Injector and detector 
temperatures were both 250°C. The oven temperature program was from 40°C (hold 2 minutes) to 250°C at 
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10°C min-1 (hold 7 minutes). Hydrogen was used as a carrier gas at a flow rate of 1 mL min-1 for FID/FPD 
(flame photometric detector) and helium at 1.3mL min-1 for MS experiments. Splitless injection mode (SPME 
desorption) employed a purge off time of two minutes. The modulation period was varied from three second 
to six seconds and modulation temperature was set at -30°C, 0°C, 40°C and 80°C during the optimisation. 
Temperature tracking was applied in all GC×GC-TOFMS experiments, keeping a constant ΔT of 130°C 
between the oven and modulator, starting at 0°C for the LMCS cryotrap.
Table 2.1 Column sets used in all 1D and 2D GC experiments
System 1D columna 2D columnb
GC×GC-FID BP20 DB-1
BPX50 BPX5
BPX5 BPX50
BPX5 BP20c
GC×GC-FPD BPX5 BP20
GC×GC-fastTOFMS BPX5 BP20
GC-accTOFMS HP5
GC-qMS BPX5
a: Dimension: 30m x 0.25mm; 0.25μm
b: Dimension: 1m x 0.1mm; 0.1μm, except otherwise stated
c: 1.4m x 0.1mm; 0.1μm
All MS detectors were operated at -70 eV ionisation energy in the mass range from 45m/z to 500m/z. One 
scan s-1 acquisition rate was used with all single column experiments (qMS and accTOFMS), 20Hz in all 1D 
and 50Hz in all GC×GC experiments with two-column sets (FID, FPD and fastTOFMS). Components were 
tentatively identified against NIST05 (National Institute of Standards and Technology, Gaithersburg, United 
States) and Wiley 7 (John Wiley & Sons, New York, United States) commercial MS databases by using 
probability-based matching algorithm (qMS only) or NIST algorithm. When in doubt, accTOFMS was used for 
component confirmation. Automated spectra deconvolution and peak finding features of ChromaToF (Leco 
Corporation) acquisition and data processing software have been applied in all fastTOFMS experiments. 
S/N threshold of 100 was set for peak detection (except otherwise stated) and minimum acceptable match 
threshold (Mitrevski et al. 2008) of 800 (on 0–999 scale) for component identification. All 2D plots are 
presented with 50 contour levels from 10±2 pA to 50 pA (FID) or 180k–680k counts (TOFMS).
Statistical analysis
Data were processed using the Statistica Software release 8.1 package (Statsoft, Maison- Alfort, France). 
The 24 ecstasy tablets were gathered in eight groups by their post-TB physical characteristics (logo, colour, 
diameter and thickness) and intelligence information. The raw dataset (53 observations x 16 variables) 
consisted in the abundance of the targeted compounds determined by GC×GC-TOFMS for each replication 
of each tablet sample plus five replicates of one sample (XTC5). The data were normalised according to the 
procedure described by Bonadio et al. (2009, 2008). The procedure consists of the calculation of the 4th 
square root of the ratio between the abundance of the targeted compound and the sum of the abundance 
21
Innovative solutions for enhanced illicit drugs profiling using comprehensive two-dimensional gas chromatography and 
mass spectrometry technologies
of all compounds selected for the profiling. To determine which compounds distinguished between the eight 
groups, a one-way analysis of variance (ANOVA) was performed on raw and normalised datasets according 
to the model—abundance of the compound—group of tablets, p<0.05. Principal component analysis was 
performed on raw and normalised data sets to visualise the structure of the data. In order to confirm the ability 
of some compounds to differentiate the samples according to their country of seizure, a one-way ANOVA was 
performed on the normalised data set according to the model—country, p<0.05.
In order to determine a set of ‘orthogonal’ compounds enabling to discriminate at best the eight groups of 
ecstasy tablets, a linear discriminant analysis (LDA) was carried out on the normalised dataset. For processing 
the LDA, the dataset was divided into two independent subsets
•	 a ‘learning’ dataset (n=35) for the generation of candidate discriminative models; and
•	 a ‘test’ dataset (n=18) for the assessment of the robustness of the model.
For the discriminant analysis, only the three most relevant variables were selected according to the ‘best 
subset’ algorithm. The best subset of three variables was selected from the learning dataset according to the 
best subset algorithm where the misclassification rate was chosen as the criterion of ranking between all the 
models constructed on three variables.
Results and discussion
Separation of volatile components in ecstasy on different 
column sets
The concept of orthogonality in GC×GC aims to maximise the utility of the 2D separation space by having 
minimum correlation between the retention mechanisms of 1D and 2D (Ryan, Morrison & Marriott 2005). 
In cases where this extreme is desirable and can actually be achieved, the GC×GC approach is capable of 
generating a large number of points of reference and so is effective for profiling complex mixtures. In the case 
of chemico-legal profiling of illicit substances, differential analyses of this type permits ideally results in the 
derivation of relationships such as batch-to-batch association, supply chain tracking and mapping of synthetic 
and geographic origins.
The selection of column sets that have demonstrable orthogonality is sample dependent and must be 
derived from either a detailed understanding of the sample composition or by empirical methods. As the 
former is rarely achieved without first completing the orthogonal analysis, phase polarity is usually deduced 
using the ad hoc application of solvation parameter models such as that derived by Abraham, Ballantine and 
Callihan (2000). In practice, the phase polarity is more commonly interpreted in terms of a simplified polarity 
scale, such as that developed by Wynne, DiFeo and Dawes (nd) in which spatial restriction to interaction are 
normalised and bonding considered according to the π- or n-type character in the analyte-phase interactions.
In the case of ecstasy and its likely precursors, by-products and contaminants, predictive analyte chemistry 
suggests that orthogonality to a simple van der Waals type retention is likely to be found by using an aromatic 
chemistry (on the basis of the 3,4-methylenedioxybenzyl moiety) or a hydrogen bonding or n-electron 
chemistry (on the basis of the amine moiety). Accordingly, we have coupled these polar chemistries (P) with 
less polar phases (NP) in two dimensional sets to test for separation of components in the ecstasy samples.
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BP20/DB-1
A BP20/DB-1 column combination was used as a P–NP column set to test the separation of volatiles in 
ecstasy samples. Despite the reasonably good spread of the components on the 2D plot and their very good 
peak shape (see Figure 2.1), the lowest number of components has been detected with this column set 
(proved when all column sets were tested). This fact together with the strongly tailed MDMA peak on the 1D 
column, which is most likely due to the strong H-bonding and weak n-π* interaction with the stationary phase, 
has limited the applicability of this column set in ecstasy volatiles profiling.
Figure 2.1 2D plot of ecstasy sample XTC4 analysed by SPME on BP20/DB-1 column set. The highly tailed 
MDMA peak on 1D column is annotated
 
 
BPX50/BPX5
The second P–NP column set applied for separation of volatiles in ecstasy tablets was BPX50/BPX5 (see 
Figure 2.2). Similarly to the separation on the opposite phase column set (BPX5/BPX50, see Figure 2.4 later), 
increased peak signal was obtained due to the very narrow peaks on the 2D column, with the components 
spread in a narrow band on the 2D plot along the 1D time. Three different ecstasy samples (which were later 
proved to be different) showed similar GC×GC profiles here, but this is due to the poor separation on the 
2D column which compresses the volatile components into the narrow band noted above. The separation 
mechanism in BPX5 based on the weak H-bonding and stronger π-π* interaction is not enough to separate 
the ecstasy constituents on 2D. This makes the column set unsuitable for GC×GC profile comparison since 
it does not offer much advantage over classical 1D GC separation. The major feature of this column set was 
the clear separation of highly NP components; that is, alkanes and siloxanes, from the rest of the ecstasy 
constituents, which have the longest retention on BPX5. However, peaks as narrow as 50ms peak width at 
half height (w1/2) on 2D column have been obtained.
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Figure 2.2 Representative 2D plots of ecstasy samples XTC3 (a) XTC4 (b) XTC5 (c) and a blank (d) analysed 
on BPX50/BPX5 column set. Note the similarity of the profiles, even though the samples proved to be 
different
 
BPX5/BPX50
The separation of volatiles in ecstasy tablets on a NP–P column set was first conducted using BPX5/
BPX50. While increased peak signal was obtained when compared to the other column set (BP20/DB-1), 
the components are located in a narrow band in the 2D axis on the 2D plot along the 1D time, showing poor 
spread in 2D space (see Figure 2.3). This makes the column set unsuitable for analysis of volatiles since 
it does not offer much advantage over classical 1D separation. However, good peak shape (narrow and 
symmetrical) has been obtained. The separation on this and the previous column set incorporating the BPX50 
polar column suggests that the selectivity of the BPX50 phase is relatively poor towards chemical constituents 
of the sample. However, this phase is known to be more selective (retaining) towards aromatic compounds. 
It seems that all sample constituents show similar ‘aromaticity’ and the selectivity towards BPX50 is in some 
way ‘normalised’ to give only a narrow separation band. The separation appears to be superficially the same 
as a boiling point elution, thus reducing the orthogonality of this column set.
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Figure 2.3 2D plot of ecstasy sample XTC4 analysed by SPME on BPX5/BPX50 column set
 
BPX5/BP20
The second NP–P column set tested was BPX5/BP20. This column set showed a good spread of 
components over the 2D space, as well as having good peak shape (see Figure 2.4). Despite the unresolved 
cluster of components at the lower right side region of the 2D plots, which is partially contributed to by 
siloxanes from the SPME fibre and column bleed, most of the components are well separated and spread 
within 2D space. It seems the spread of the components on the 2D column (BP20) is mainly due to the 
column selectivity towards the aliphatic hydrocarbon chain in sample constituents rather than the selectivity 
towards the aromatic moiety.
This column set reveals a high number of volatiles in ecstasy samples, offering complex sample profiles 
for easier sample comparison. Three different volatile ecstasy profiles are shown in Figure 2.4, along with 
a representative blank. Closer examination of the profiles reveals some easily noticeable differences in 
component ratios between samples and some differences in presence/absence of other components. 
Because of this, all further experiments were conducted on this column set. However, unambiguous 
identification of the components is necessary in order to avoid comparison of samples based on non-drug 
origin related markers. While a large number of reference components are required for identification of 
components based on GC×GC-FID, availability of MS detection provides valuable molecular information of 
sample composition.
FPD is a highly sensitive and selective detection system toward P- and S-containing components. Its 
potential in GC×GC format for ecstasy profiling has been investigated by using this column set. However, 
only a few components (data not shown) have been detected on both the P- and S-channel. Although some 
infrequent and unusual components can be of great value in sample-to-sample comparison, the few detected 
components with similar ratio in the analysed ecstasy samples has been shown to be of little value in ecstasy 
volatile profiling by using FPD.
On the basis of the good separation found for the present NP–P column set, it was decided that a subset 
of 16 compounds would be selected as representative of different ecstasy samples, to demonstrate sample 
similarity and heterogeneity. This is further discussed below.
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Figure 2.4 Representative 2D plots of three different ecstasy samples analysed by SPME on BPX5/BP20 
column set, at -30°C modulation temperature and 6 s modulation period: (a) sample XTC3; (b) sample XTC4; 
(c) sample XTC5 and (d) a blank. Note the differences between profiles, especially as suggested by the 
circled regions. The annotated components in sample XTC3 are selected for 2tR and area reproducibility
 
Optimization of some GC×GC parameters
Modulation period
It has been shown in subsequent experiments that a five to six second modulation period is necessary in 
order to elute some polar components from the highly polar 2D column, under the proposed conditions, 
within one modulation period value. The most retained components from the selected 16, along with various 
fatty acids, were the most polar 1,3-benzodioxole-5-MeOH and benzyl alcohol. Although they showed a high 
level of tailing on the 1D column, they were well modulated on the 2D column which makes identification and 
integration much easier (Mitrevski, Wilairat & Marriott 2010a).
Modulation temperature
Not surprisingly, we have found that lower modulation temperature offers better peak shape. However, 
consistent with conclusions in previous work on sterols (Mitrevski et al. 2008), experience reveals that higher 
modulation temperature favours better elution of some of the higher boiling point components (data not 
shown). Whilst a modulation temperature of -30°C offers the best overall peak shapes, modulation at 0°C 
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gave acceptable results since none of the early eluting components were selected for profiling. All subsequent 
experiments, unless otherwise stated, were carried out at this modulation temperature.
Reproducibility of peak area and 2D retention time in GC×GC-FID
The reproducibility of the GC×GC method was confirmed by running five fresh aliquots of the same sample on 
the above column set. Very reproducible profiles were obtained (replicate traces not shown), even in terms of 
the minor components usually not seen in 1D GC chromatograms. The 2tR and the peak area reproducibility 
of three selected components (shown in Figure 2.4a) are given in Table 2.2. Around one percent RSD for 
2tR and six to seven percent RSD for summed modulated peak area were obtained for all three selected 
components. The results for 2tR reproducibility here are in good agreement with previous findings (Mitrevski, 
Wilairat & Marriott 2010a; Shellie, Xie & Marriott 2002).
Table 2.2 Reproducibility of the 2D retention time and the peak area of three selected components in 
GC×GC-FID analysis of ecstasy sample XTC3. Selected components are annotated in Figure 2.4a. n=5
component 1 component 2 component 3
2tR Average (s) 2.736 3.228 2.328
RSD (%) 1.20 0.83 1.15
Area Average (pA s) 13.19 14.56 48.05
RSD (%) 6.2 7.0 6.1
Ecstasy volatiles profiling on GC×GC-TOFMS
The two column sets incorporating BPX50 and BPX5 were eliminated from further experiments due to the low 
components spread over the 2D separation space. This is greatly contributed to by the poorer orthogonality 
of these column sets towards sample constituents compared with the orthogonality of BPX5/BP20 and BP20/
DB-1. The phase selectivity of BP20 based on H-bonding interactions apparently plays a key role in the 
orthogonality of these column sets for this kind on components.
Both BP20/DB-1 and BPX5/BP20 gave good spread of the ecstasy volatiles in the 2D plots. However, 
because of the strong tailing of the large MDMA peak on the 1D BP20 column, we decided to proceed with 
all further experiments on the BPX5/BP20 column set. One method difference involved replacing the 1.4 m 2D 
column with a 1.0 m long 2D column of the same type, to avoid any wraparound (ensuring 2tR<PM) while still 
keeping good spread of the components on the 2D plots.
Identification of components on GC×GC-TOFMS
Automated deconvolution and peak finding data processing of GC×GC-TOFMS chromatograms on this 
column set revealed the identity of the most of the higher abundant components with high match quality. The 
high match quality of TOFMS spectra against commercial MS databases (NIST05 and Wiley7) agreed with our 
previous conclusion (Mitrevski et al. 2008; Mitrevski, Wilairat & Marriott 2010a) that match quality decreases 
as molecular mass and higher mass ion fragmentations in the mass spectra increase. The highest molecular 
mass components which were detected and identified in HS-SPME sampling were N-formyl- (RMM 221) and 
N-acetyl-MDMA (RMM 235), compared with as high as RMM 560 components in our previous study.
Through use of ChromaToF software automated detection and identification, an extensive number of 
components in ecstasy volatile profiles have been recorded. In some ecstasy samples, up to 450 components 
out of a total of 1,200 have been tentatively identified at a S/N threshold of 100 and minimum acceptable 
match threshold of 800, of which several tens were replicates and background components (mainly siloxanes, 
see Figure 2.4d). By comparison, only 50 out of 200 detected peaks in total were identified against MS 
databases by using PBM algorithm in GC-qMS experiments under similar chromatographic and integration 
conditions (data not shown). This demonstrates that ecstasy volatile profiles in GC×GC format are complex, 
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that many more peaks can be positively identified and that GC×GC approaches should be appropriate for 
sample-to-sample comparison and grouping. Representative GC×GC-TOFMS 2D plot of an ecstasy sample 
analysed on BPX5/BP20 column set is given in Figure 2.5.
Figure 2.5 Representative GC×GC-TOFMS 2D plot of ecstasy sample analysed on BPX5/BP20 column set. The 
location of selected 16 components for profiling, along with the identified fatty acids, is shown on the plot
 
Selection of components for profiling and their location on the 2D plot
Selection of components for profiling was firstly based on previous work (Bonadio et al. 2008; Gimeno et al. 
2002; Weyermann et al. 2008; van Deursen, Lock & Poortman-Van Der Meer) according to components that 
have been previously employed for profiling in 1D GC methods. Among several precursors (safrole, isosafrole, 
piperonal), intermediates (PMK) and by-products (piperonyl alcohol, PMK-OH, N-formyl- and N-acetyl-MDMA) 
with known origin, several unknown or known components with unexplained origin have also been selected. 
The structures of the 16 selected components that showed good reproducibility and were present in all tested 
samples in reasonable but variable concentrations are given in Figure 2.6. Their location on a representative 
2D plot of an ecstasy sample is given in Figure 2.5 and the peak table with their 1tR, 2tR and quantification 
ions for peak area calculation is given in Table 2.3.
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Figure 2.6 Structures of the 16 components selected for profiling. Note that most compounds incorporate 
similar aromatic functionality; this choice of compounds was not a deliberate strategy, but rather was 
completely fortuitous
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Peak area reproducibility of the selected components for profiling has been confirmed on the BPX5/BP20 
column set also in GC×GC-TOFMS format, similarly to the procedure where GC×GC-FID had been applied. 
An average of 9.1 percent RSD has been obtained with the lowest being for 1,3-benzodioxole-5-MeOH 
(6.0%) and N-acetyl-MDMA (5.8%) and the highest for benzyl alcohol (15.7%) and benzothiazole (15.5%). The 
average RSD has dropped on 7.9 percent when the three least discriminative components (3,4-MD-benzyl-
Cl, benzyl alcohol and benzothiazole) were excluded from the calculation. The last two components do not 
contain the 3,4-methylenedioxyphenyl bridge. The higher RSD in GC×GC-TOFMS format over GC×GC-FID 
format is likely related to the lower mass spectrometry reproducibility over FID reproducibility. Peak area 
reproducibility is a key issue when the aim is to discriminate samples according to their similar profiles. A poor 
reproducibility is a source of unexplained variability and contributes to lower the discrimination power of the 
distinctive compounds.
Even though the number of selected components for profiling is quite large (16), only one component (5) in 
only one sample (XTC3) was not detected at a defined S/N threshold of 100, but was detected at S/N ratio 
of 20. This is partially contributed by the strong tailing of five on the 1D column, where up to six modulation 
slices were automatically detected, integrated and summed up. Adequate integration was facilitated by the 
excellent trapping and releasing of five on the 2D column, giving narrow peaks with an average w1/2 of 
~200ms. It has been shown (later) that this tailing and low abundant component could be one of the most 
discriminative in the proposed statistical approach.
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Table 2.3 Peak table of the 16 selected components chosen for profiling with their retention times and 
quantification ions used for area calculation
Compound 1D time (s) 2D time (s) Quant. ion (m/z)
1 safrole 960 1.58 162
2 isosafrole-2 995 1.78 162
3 3,4-methylenedioxyphenylpropane (3,4-MD propane) 920 1.48 164
4 piperonal 970 2.86 149
5 1,3-benzodioxole-5-MeOH (benzodioxiole-5-MeOH, piperonyl alcohol) 1,005 4.54 152
6 3,4-methylenedioxyphenyl-2-propanone (Piperonylmethylketone, PMK) 1,080 2.58 178
7 3,4-methylenedioxyphenyl-2-propanol (PMK-OH) 1,085 2.88 180
8 unknown 147 1,150 2.420 147
9 N-formyl-MDMA 1,400 3.080 162
10 N-acetyl-MDMA 1,415 2.78 162
11 3,4-methylenedioxyacetophenone (3,4-MDAcPh) 1,050 2.62 164
12 Benzyl alcohol 670 4.24 108
13 3,4-methylenedioxytoluene (3,4-MD toluene) 740 1.68 135
14 benzylmethylketone (BMK) 760 1.98 134
15 benzothiazole 870 2.28 135
16 3,4-methylenedioxybenzylchloride (3,4-MD-benz-Cl) 990 2.30 170
On the other hand, the TOFMS detector was saturated with some of the components listed in the literature 
at their characteristic ions, for example N,N-dimethyl-3,4-methylenedioxy-amphetamine at 72m/z. Because 
of this, the component was rejected from selection. An inconvenience due to the overloading has also been 
encountered with other higher abundant components in the profiles such as PMK, piperonal and PMK-OH. 
Sometimes different modulation slices of the same component have been identified and integrated as different 
species, so manual inspection and proper data processing method (match similarity threshold for combining 
modulation slices, peak width on 2D, S/N threshold) are required. This problem was not observed with lower 
abundant components in the profiles.
Many production-specific components, generally those containing a 3,4-methylene-dioxyphenyl bridge, 
co-elute on the 1D column with some matrix components or cutting agents, but they then are subsequently 
separated on the 2D column. Figure 2.7 shows co-elution of benzodioxole-5-MeOH (5) with two other 
matrix components, with which they share the two most characteristic mass fragments of 5:135m/z with 
component x and 152m/z with component y. Note that the ecstasy sample presented in Figure 2.7 (sample 
XTC3) contains minor amount of five, in contrast to the ecstasy sample presented in Figure 2.5. The highly 
abundant and strongly tailing 1D peaks of polar organic acids can strongly interfere with some of the co-
eluting components in the profiles. For example, Figure 2.5 shows that 13 co-elutes with heptanoic acid, one 
with decanoic acid and eight with several matrix components on the 1D column. However, they are all well 
resolved on the 2D column and this facilitated by the deconvolution and automated peak finding features of 
ChromaToF software have resulted in high similarity to the commercial MS database entries.
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Figure 2.7 Extracted ion 2D plot showing the co-elution of 5 on the 1D column with two other components 
that share some common mass fragments—component x and component y have abundant 135m/z and 
152m/z daughter ions, respectively. Note that these two ions are the two most characteristic for 5. 1D GC 
will have difficulty in identifying these peaks
 
  152+135x0.1
5
 x
   y
Two out of four of the most discriminative components listed in the work of Weyermann et al. (2008) elute 
after N-formyl- and N-acetyl-MDMA and they were not detected in the samples due to their poor sorption 
on SPME fibre at the applied temperature (80°C). Several other higher boiling point components listed 
in the literature were not detected in the samples due to the SPME sampling limitation. However, many 
lower molecular weight components are detected in the profiles which could represent minor by-products, 
intermediates or impurities present in precursors used in ecstasy production and the list of the components 
selected for profiling can be further extended.
The average match quality of the 15 selected components listed in Table 2.3 (there is no entry for Unknown 
147 in the MS databases) against NIST05 and Wiley7 was 920, the lowest being for N-formyl-MDMA (813) 
and N-acetyl-MDMA (901) and the highest for isosafrole-2 (957) and 3,4-MDAcPh (965). The mass spectrum 
of Unknown 147, in a later stage confirmed as 3-(3,4-methylenedioxyphenyl)-3-buten-2-one by accTOFMS at 
3 ppm error, showed high similarity to the literature spectra7 of Unknown 44. The high match quality for low 
RMM compounds, facilitated also by the deconvolution capabilities offered by ChromaToF software, precludes 
the need for generation of a TOFMS dedicated in-house library, which was necessary in our previous study on 
higher molar mass sterols (Mitrevski et al. 2008) and anabolic agents (Mitrevski, Wilairat & Marriott 2010a).
GC×GC has demonstrated its improved separation and enhanced sensitivity over 1D GC through more 
separated and detected components in the profiles. The fastTOFMS detector performance (high speed in full 
mass spectra mode, non-skewed spectra across the peak, spectral deconvolution and peak finding features) 
fits perfectly into the GC×GC part and simply testifies to its superior identification power over 1D GC when 
coupled to this detector. However, the larger number of separated and detected components requires an 
extensive study on relationship between the newly detected components and their significance in ecstasy 
profiling.
Authentication of ecstasy tablets based on GC×GC-TOFMS 
profiling
The 24 tablets were initially classified in eight groups by their post-TB characteristics, even though samples 
from Macedonia (XTC1, XTC2 and XTC3) were all from different seizures and samples from Australia (ECS1 
to ECS5) were from a single seizure. In order to determine whether the sixteen variables chosen for profiling 
enable to discriminate these groups (supposing they all have different profiles), one-way ANOVA was 
performed on the raw dataset and confirmed the relevance of each of the 16 selected volatile compounds 
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(p<0.05). The first map of the PCA performed on the dataset (53 analysed samples x 16 compounds) shows 
that it was possible to make a clear distinction between six of these groups based on the raw data (peak area) 
provided by the GC×GC-TOFMS analysis (see Figure 2.8a). By contrast, ECS3 and ECS5 or ECS2 and ECS4 
cannot be clearly distinguished. Figure 2.8b shows the first map of the PCA performed on the same dataset 
after its normalisation by the procedure proposed by Bonadio et al. (2008, 2009). Whereas the percentage of 
variation explained by the first map was roughly the same, Figure 2.8b shows a clear separation of the eight 
groups after normalisation and confirms both the relevance of this data treatment and the suitability of the 16 
selected compounds for authentication purpose.
Figure 2.8 First map PCA differentiation of 24 ecstasy tablets carried out from the raw (a) and normalized 
(b) abundances of the 16 selected components. The eight groups are annotated by their names beside each 
group and the country of seizure is annotated by empty circles (Macedonia) or empty squares (Australia)
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In addition to the clustering of tablets from different seizures with the same post-TB (XTC samples) 
and differentiation between the eight groups, Figure 2.8b also evidenced a clustering of Australian and 
Macedonian samples. The examination of the variable projection on the PCA first map (data not shown) 
shows that Macedonian samples were found to be rich in N-formyl-MDMA and N-acetyl-MDMA and poor in 
3,4-MD-propane and 3,4-MD-acetophenone compared with Australian samples. One way ANOVA confirmed 
this significant country effect (p<0.05) for the four variables with Fisher-F values ranging from 57 to 386.
In order to determine the best subsets of variables enabling the discrimination of the eight groups, an LDA 
was applied on the normalized data matrix. Several combinations of three compounds chosen out of the 16 
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were shown to be suitable to classify 100 percent of the samples in both learning and test subsets of the 
dataset. Figure 2.9 shows the discrimination obtained in the three dimensional orthogonal space generated by 
3,4-MD-Acetophenone, 1,3-benzodioxole-5-MeOH and Unknown 147.
Figure 2.9 Three dimensional score plot of normalised abundances of three components selected by LDA, 
showing clear discrimination of the eight groups of ecstasy tablets
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Even though synthesis route elucidation was not focus of the present paper, several components specific for 
country of seizure have been detected. 2-(dimethylamino)-2-methyl-3-(3,4-methylenedioxyphenyl)-propanenitrile, 
shown to be a marker for reductive amination by using cyanoborohydride (NaBH3CN)45, has been detected 
in different proportions only in samples from Macedonia. Its GC×GC-TOFMS spectrum is given in Figure 2.10. 
The difference in the reduction pathway could be one of the reasons for obtaining different profiles between 
samples according the country of seizure. Interestingly, the presence of this component in samples from 
Macedonia could not be confirmed with accTOFMS even though the relative location on 1D GC chromatogram 
and accurate mass were available. The reason is probably the presence of this component at low levels, where 
the compression effect of the modulator and the relatively low m/z of the base mass fragment (97m/z) favour 
its detection and identification in GC×GC format. As a reminder, the sensitivity of fastTOFMS is biased against 
higher masses (Mitrevski et al. 2008; Mitrevski, Wilairat & Marriott 2010a, 2010b).
Figure 2.10 Mass spectra of 2-(dimethylamino)-2-methyl-3-(3,4-methylenedioxyphenyl)-propanenitrile, a 
marker for cyanoborohydride reduction of PMK, found only in samples from Macedonia
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Two other unknown components, whose mass spectra are given in Figure 2.11, have been detected only 
in samples from Australia. This could be another reason for the difference in the profiles between samples 
from the two countries. Even though the initially annotated Unknown 166 has not been identified against MS 
databases, the mass spectrum (see Figure 2.11a) resembles the mass spectrum of piperonyl methyl ether, a 
component previously reported as an impurity in ecstasy samples (van Deursen, Lock & Poortman-Van Der 
Meer 2006). The identity of initially annotated Unknown 208 is still unknown but the presence of 135 m/z ion 
fragment in its mass spectrum (see Figure 2.11b) suggests it could be a 3,4-methylenedioxyphenyl derivative. 
Many more components are detected in extracted 135m/z GC×GC chromatograms (data not shown), which 
suggests that the number of potential markers could be much higher than the selected 16 components.
Figure 2.11 Mass spectra of Unknown 166 (a) and Unknown 208 (b) two components detected only in 
samples from Australia
50 100 150 200 250 300
0
25
50
75
100
105 149
166
135
51 77
re
l. 
ab
un
da
nc
e 
(%
)
m/z
Unknown 166
   
50 100 150 200 250 300
0
25
50
75
100 Unknown 208
76
58
164
135
re
l. 
ab
un
da
nc
e 
(%
)
m/z
208
 
34
Chapter Two
Conclusion
The purpose of this Chapter is to show the enhanced separation efficiency of GC×GC over classical 1D GC 
and to prove its applicability in ecstasy impurity profiling. Different column set combinations gave different 
profiles, with components spread over 2D space in a different pattern. The BPX5/BP20 column set has shown 
the best separation, with maximum use of the 2D separation space among the tested column sets.
General advantages of GC×GC over 1D GC applies also in ecstasy volatiles profiling. The modulation process, 
combined with SPME concentration and sampling, leads to almost all selected components being detected 
at S/N threshold of 100. Some components previously reported in the literature as being relevant to ecstasy 
profiling are rejected due to the TOFMS saturation at its characteristic mass fragment. The incorporation of 
highly tailed components on the 1D column in the presented metric, which is always problematic in classical 
1D GC and limits the selection of these components for profiling purposes, is facilitated due to the modulation 
process involved in GC×GC which captures a larger area proportion of such peaks. Combined with the 
increased separation efficiency, enhanced sensitivity and retaining the full mass spectra information content 
of targets, non-targets and the matrix, extends the possibility of detecting more markers and route-specific 
components, especially low abundant polar components (ie component 5). However, the work should include 
larger sample set in order to construct robust and generic model for sample classification and discrimination.
GC×GC-TOFMS can be successfully applied to ecstasy impurity profiling. The main drawback of the method 
is its high investment cost. Peak integration, even facilitated by the compression effect of the modulator, can 
be an issue since more ‘slices’ have to be integrated, properly identified and combined in one total peak area. 
This is especially true for highly abundant components such as PMK, piperonal and PMK-OH. This makes the 
method more operator-dependent than the current GC-MS profiling methods. On the other hand, automation 
in data processing (detection, identification and integration) with low abundant components appears to work 
better than in GC-qMS.
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Chapter Three: 
Application of Comprehensive Two-Dimensional Gas 
Chromatography in Heroin and Cocaine Profiling
Introduction
Cocaine is a purely natural component derived from coca leaves (Erythroxilym coca). Its illegal production 
involves several consecutive extraction and purification steps, leaving the main component unchanged from 
its source to the final product. However, many naturally occurring components in coca leaves are co-extracted 
and so are present in the final product, giving rise to its total profile. Tropacocaine (TPC), ecgonine methyl 
ester (EME), cis- and trans-cinnamoylcocaine (CCC and TCC, respectively) and cuscohygrine are the most 
frequently encountered in cocaine samples. Others such as hygrine, trimethoxycocaines and trimethoxy-
tropacocaines are present in minor amounts in coca leaves or are largely removed during the extraction 
process; they are less frequently found in cocaine samples (Casale & Moore 1994; Moore et al. 1995). 
Special extraction methods, such an ion-pairing and column fractionation (Casale & Moore 1994) have been 
developed in order to effectively quantify the presence of natural impurities. Some of them, such as truxillines, 
show poor chromatographic behaviour so reduction to simpler molecules and their derivatisation is required 
for their detection (Moore & Casale 1994; Moore et al. 1994).
The process of purification usually involves an oxidation step by potassium permanganate, where many by-
products are generated. The bulk of them are intentionally removed, such as cis- and trans-cinnamoylcocaine, 
but many more are unintentionally formed during the poorly controlled oxidation step. N-norcocaine, 
N-benzoylnorecgonine methyl ester and N-formylcocaine have been formed in over-oxidised cocaine samples 
(Ensing & Hummelen 1991). Four diasteromeric of 2,3-dihydroxy-3-phenylpropionylecgonine methyl esters 
from incomplete oxidation of cis- and trans-cinnamoylcocaine have been detected in cocaine samples (Casale 
et al. 2007). Due to their highly polar character, derivatisation prior to GC analysis is required. Another group 
of by-products has been detected in Peruvian cocaine base samples purified by using ethanol instead of 
permanganate oxidation. Several ethyl homologues of natural tropane alkaloids have been detected in these 
samples due to the transesterification (Casale, Boudreau & Jones 2008), after ion-pair chromatography 
fractionation and concentration. Finally, many hydrolysis products are formed during the production steps or 
during prolonged storage under inappropriate conditions. Hydrolysis usually occurs at the ester linkage so 
cocaine yields benzoylecgonine, ecgonine methyl ester, ecgonine and benzoic acid. Trace amounts of other 
hydrolysis products are formed from minor tropane alkaloids
Heroin, on the other hand, is a semi-synthetic drug obtained by acetylation of morphine, a purely plant-
derived alkaloid isolated from the latex of opium poppy (Papaver somniferum). Many naturally occurring 
alkaloids in opium poppy (codeine, thebaine, noscapine, papaverine etc) are co-extracted with morphine and 
undergo acetylation, giving numerous by-products. This is especially true for the raw processed morphine, 
where the variety in the impurities, their acetylation products and degradation by-products, and variety in their 
concentrations give rise to the total heroin profile. At least nine degradation products of thebaine (Allen et 
al. 1984) and 18 of papaverine (Toske et al. 2006) have been detected when these components have been 
boiled in acetic anhydride. Acetylation of highly purified morphine samples result in heroin that lacks these 
trace components, leading to simpler profiles.
36
Chapter Three
The level of different manufacturing by-products and naturally occurring alkaloids in cocaine and heroin 
samples vary significantly—about two to three orders of magnitude (Moore & Casale 1994). The concentration 
range of the impurities, as well as the variety in their chemistry, require various methods for extraction, 
concentration, derivatisation and detection. This is especially true for cocaine where many different cocaine 
profiling methodologies have been applied.
The generic approach to major component profiling of cocaine and heroin (Dufey et al. 2007; Geyer et al. 
1998; Johnston & King 1998; Klemenc 2001; Lociciro et al. 2008) is based on sample dissolution, optional 
prior derivatisation and injection into the GC port. Sample comparison is based on the normalised area of 
each of the selected analytes against the peak area of cocaine, the peak area of whole morphine (sum of 
morphine, monoacetylmorphine and diacetylmorphine), or the peak area ratio against internal standard. 
The chromatograms do not appear complex because of the very few target components at relatively high 
concentrations in the profiles. Cocaine, cis- and trans-cinnamoylcocaine, tropacocaine, ecgonine, benzoyl 
ecgonine and EME are mainly used in cocaine profiling; meconine, acetyl codeine, 6-monoacetyl morphine 
(6-MAM), papaverine and noscapine are often used in heroin profiling. A separate cocaine and heroin profiling 
method based on solvents occluded in their crystals have been applied as a complementary technique by 
using head space (Cartier, Gueniat & Cole 1997; Dujourdy & Besacier 2008; Morello & Meyers 1995) or SPME 
sampling (Chiarotti, Marsili & Moreda-Pineiro 2002). The information content has been limited to several 
solvents detected in the samples, originating from the purification and base-to-salt conversion process 
applied. The most frequently encountered solvents are toluene, acetone, diethyl ether, methyl ethyl ketone and 
methylene chloride in cocaine samples (Dujourdy & Besacier 2008) and acetic acid, acetone and diethyl ether 
in heroin samples (Morello & Meyers 1995; Chiarotti & Fucci 1988). Additional methods for sample-to-sample 
comparison and geographic origin determination are based on isotope ratio (Besacier et al. 1997; Ehleringer et 
al. 1999; Galimov et al. 2005; Hays et al. 2000; Ehleringer et al. 2000) or trace metal contaminants (Myors et al. 
1998; Infante et al. 1999; Violante et al. 1992; Bora, Merdivan & Hamamci 2002; Bermejo-Barrera et al. 1999).
Advanced heroin profiling methodology has been generally based on acidic and neutral organic impurity 
extraction (Neumann & Gloger 1982), concentration and subsequent analysis on GC coupled to FID 
(Neumann & Gloger 1982; Besacier et al. 1997) or MS detector (Toske et al. 2006; Myors et al. 2001). 
Sixteen impurities have been selected in the most comprehensive study aimed at harmonising the method 
for retrospective comparison and data exchange between three well-equipped and experienced forensic 
laboratories (Stromberg et al. 2000). Various limitations of the GC technique have been identified as the main 
reason for the poor inter-lab reproducibility. Recently, comprehensive 2D GC has been applied in heroin and 
cannabis impurity profiling with pixel-based chemometric processing (Groger et al. 2008). Even though only 
nine out of 16 components reported in the literature have been detected in a relatively simple 2D profile, the 
group classification has matched the results found by well-established 1D GC impurity profiling methods and/
or the forensic background of the samples. However, the applicability of GCxGC is poorly justified for samples 
where no coelution on the 2D column have been observed and the problem could be solved by using well-
established 1D GC.
The most comprehensive cocaine profiling approach so far has been developed and used by the Special 
Testing and Research Laboratory at the Drug Enforcement Administration. The approach is based on six 
independent cocaine profiling methods for sample comparison analyses, geographic origin studies and 
solvent determinations (Moore & Casale 1998). It combines different and separate preparation steps, from 
simple derivatisation, through head space sampling of volatiles, to components reduction and column 
chromatography fractionation. Furthermore, different detection systems have been used for each class of the 
components (FID, ECD, MSD).
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However, none of the profiling methods available offers high information content and simplicity at the same 
time. Either the methods are complex and time consuming but offer high amount of data, or they are simple 
but offer limited information content. In this paper, we present the application of comprehensive two-
dimensional gas chromatography as an alternative, with simple and reasonably high information content 
method for cocaine and heroin sample discrimination. The method is based on SPME sampling of volatiles 
and semi-volatiles in cocaine and heroin samples, subsequent separation on non-polar/polar column set 
and TOFMS detection. Even though many components currently used in profiling methods, especially those 
that require reduction and derivatization (truxillines), and higher molecular mass components (ie cis-, trans-
cinnamoylcocaines and their analogous, papaverine and thebaine acetylation by-products) are not detected, 
the method offers a complex profile composed of many other sample constituents. Several potential markers 
have also been detected in highly purified heroin samples from SEA. To the best of our knowledge, this is 
the first ever application of GC×GC in cocaine profiling and the second one in heroin profiling, but this time 
focused on more complex profiles of heroin volatile and semi-volatile components.
Experimental
Gas chromatography and mass spectrometry conditions for profiling of volatiles in heroin and cocaine 
samples were the same as the conditions given in ecstasy profiling (unless otherwise stated).
Analysis of impurities in heroin samples extracted by L/LE was performed in 1D and GC×GC mode by 
using BPX5/BPX50 and BPX50/BPX5 column sets. For column dimension details see Experimental section 
in ecstasy profiling in Chapter 2. 1D GC experiments were carried out either on a single column (qMS and 
accTOFMS) or under the same conditions as in GC×GC, except the modulator was off and the acquisition 
rate of fastTOFMS detector was reduced to 20 Hz. Therefore, in this case, the 1D GC system comprised 
a long column directly coupled with a short column and while this can be termed a multi-chromatography 
system according to Hinshaw and Ettre (1986) and discussed elsewhere (Marriott & Kinghorn 2000), the 
second very short column is anticipated to lead to negligible variation in peak properties such as width. The 
applied temperature program (Stromberg et al. 2000) was from 160°C to 320°C at 6°C min-1 (hold 6 minutes) 
at a flow rate of 1.3mL min-1 (He). Splitless mode with a purge time of one minute was applied in both modes 
because of the low sensitivity of the method in 1D GC mode.
Comparison between major component analysis of cocaine samples in 1D GC and GC×GC mode has been 
done on the same column set, under different oven temperature program (Lociciro et al. 2007). The following 
conditions were applied—isothermal for one minute at 180°C then increased to 275°C at 4°C min-1 rate and 
hold at this temperature for 2.25 minutes. One µL of the sample was injected in split mode at 20:1 split ratio.
Results and discussion
GC×GC versus 1D GC in major component analysis of cocaine 
and heroin
Based on previous results and our experience in illicit drug analysis, GC×GC was not expected to offer much 
advantage over 1D GC in term of major components analysis. The only advantage expected was seen in 
some increase of sensitivity for low abundant components. A comparison of GC×GC-FID and 1D GC-FID 
chromatograms of the same cocaine sample is presented in Figure 3.1.
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Figure 3.1 Comparison of (A) 1D GC and (B) GC×GC cocaine major components profiles. BPX5 has been used 
in 1D GC and BPX5/BP20 column set in GC×GC format. Note the difference in the peak width of cocaine on 
1D column
Despite the two well-separated pair of coeluting components in 1D GC at 11.0 minutes and 19.5 minutes, 
there is no much improvement in GC×GC 2D plot. By contrast, several components eluting immediately 
after the cocaine in 1D GC are overlapped by its huge and tailing spot on 1D column in GC×GC format. 
Peak tailing on 1D of overloaded components in GC×GC is mainly contributed to by the inefficiency of the 
modulator to effectively remobilise the trapped (overloaded) portion onto the 2D column. The spot width on 
1D can be minimised either by increasing the temperature of the modulator (to ease the remobilisation), or by 
decreasing the modulation period (less component cryotrapped per cycle). However, both can significantly 
alter the overall 2D plot, either by inefficient trapping of other components (at higher modulation temperature) 
or by increasing the chances of wraparound (shorter program temperature). In general, the example confirmed 
our proposition that GC×GC has no advantages over 1D GC when dealing with simple component mixtures. 
Similar results for comparison between 1D and 2D GC of main components have been obtained for heroin 
samples (data not shown).
GC×GC versus 1D GC in impurity profiling of heroin
Heroin organic impurities have been analysed on both, BPX5/BPX50 and BPX50/BPX5 column sets, 
the second one being similar to the column configuration used in Groger et al. (2008). The first column 
configuration gave good spread of components on 1D BPX5 column with relatively strong retention and 
almost no coelution revealed on 2D BPX50 column (see Figure 3.2A). The retention on BPX50 is probably 
contributed by the high aromaticity content of the impurities. Despite the expected enhancement in sensitivity, 
there was not much improvement in separation compared to the well-established 1D GC heroin profiling 
methods (see Figure 3.2B).
Since the column choice for separation of high boiling point components in GC×GC is limited to the few 
high temperature limit columns, the logical step was to check the separation on BPX50/BPX5 column 
configuration. As expected (see Figure 3.3), most of the components have shown strong retention on the 1D 
BPX50 column, with some better spread of components on 2D BPX5 column and few coelutions of minor 
components revealed on 1D BPX5 column. However, the strong tailing of the major polar components on 1D 
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column, especially the later eluting, has rejected this column set as an appropriate one for heroin impurity profiling. 
The major benefit of using this column set, among the good spread and peak shape of early eluting components, 
was the clear separation of straight chain hydrocarbons and siloxanes from other components (see Figure 3.3). 
Less tailing on 1D and more on 2D column has been obtained in the results of Groger et al. (2008).
Figure 3.2 Comparison of a heroin impurity profile in (A) GC×GC with the profile in (B) 1D GC
Figure 3.3 Heroin impurity profile on BPX50/BPX5 column set. Note the significant tailing of components 
on 2D, and especially on 1D column for late eluting components. Siloxanes and n-alkanes homologues 
are denoted
B siloxanes 
n-alkanes 
Cocaine and heroin volatiles in 1D GC
A sampling procedure similar to the one explained in our previous work on ecstasy profiling (see Chapter 
2) has been applied in order to check if volatiles and semi-volatiles cocaine and heroin profiles are complex 
enough for profiling in GC×GC format. Since known components used in cocaine and heroin profiling 
methods are expected to be generally less volatile than the ones used in ecstasy samples, prolonged 
equilibration and absorption time was applied. Chromatograms of three different cocaine samples analysed 
on GC-qMS are given in Figure 3.4. Reasonable complex and different profiles are obtained, showing many 
coelutions. However, only a small number of components were identified with a similarity above 800 (out of 
999). The number of identified components was improved by applying the AMDIS32 (NIST), an automated 
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deconvolution and identification software, but still the number of components was far below the number of 
components later identified by GC×GC-TOFMS. Similar results have also been obtained for three different 
heroin samples. At least the profile looked promising for the next step, comprehensive two-dimensional gas 
chromatography.
Figure 3.4 GC-qMS comparison of volatile and semi-volatile component profiles of three different cocaine 
samples. (A) sample Ca, (B) sample Cb, (C) sample Cc
Separation of volatile and semi-volatile components in cocaine 
and heroin samples on different column sets in GC×GC format
2D GC offers more choices in term of column selection over 1D GC because two-column combinations are in 
play in each system. As stated previously, the choice for higher molecular weight components is limited due to 
the temperature limitation of highly polar columns. Conversely, the choice is much wider for volatiles and semi-
volatile components eluting up to 260°C. The separation of volatiles in cocaine and heroin samples has been 
tested on four different column sets—two non-polar (NP)–polar (P) and two P–NP. Different profiles for each 
column set have been obtained, each offering advantages and disadvantages over the other column sets.
BPX50/BPX5
The first column set applied in cocaine volatiles separation was BPX50/BPX5. Three different cocaine samples 
(proved to be different in a later stage) have shown different profiles, but the components were spread on 
a rather narrow band along the 1D column (see Figure 3.5). It seems that the separation mechanism in 
BPX5 based on the weak H-bonding and stronger π-π* interaction is not enough to separate the cocaine 
constituents on 2D column. This makes the column set unsuitable for GC×GC profiles comparison since it 
does not offer much advantage over classical 1D GC separation.
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Figure 3.5 Representative 2D plots of volatiles in cocaine samples Ca (A), Cb (B), Cc (C) and a blank (D) 
analyzed by SPME on BPX50/BPX5 column set. Note the similarity of the profiles, even the samples have 
proven to be different
The major feature of this column set was the clear separation of highly non-polar n-alkanes from the rest of 
the matrix, having the longest retention on 2D column (BPX5). However, narrow peaks on 2D column have 
been obtained. Interestingly, very similar dispersion on 2D column has been obtained also for volatiles in 
heroin samples, which were spread rather in a narrow band along the 1D column. Similar profiles have been 
obtained for samples Ha and Hb and slightly different for sample Hc (see Figure 3.6), even though all three 
samples proved to be different.
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Figure 3.6 Representative 2D plots of volatiles in heroin samples Ha (A), Hb (B), Hc (C) and a blank (D) 
analysed by SPME on BPX50/BPX5 column set. Note the similarity of the profiles in (A) and (B), even the 
samples have proved to be different
BP20/DB-1
A BP20/DB-1 column combination was used as a second P–NP column set to test the separation of volatiles 
in cocaine and heroin samples. Very few components in sample Cc (see Figure 3.7) have been detected by 
contrast with the 2D plot of the same sample obtained on BPX50/BPX5 column set (see Figure 3.5C). Please 
note that the same contour level has been used in all FID 2D plots. However, good spread on 2D space and 
good peak shape have been obtained, excluding some components showing tailing on 1D column (most 
probably the polar ones). Similar results have been obtained on 15 m FFAP as a 1D column, showing similar 
profiles; however, at a shorter total runtime (due to the reduced 1D length).
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Figure 3.7 2D plot of volatiles in cocaine sample Cc analysed by SPME on BP20/DB-1 column set
Chromatographic behaviour of volatiles in heroin (see Figure 3.8) on this column set has been found similar 
to the cocaine volatiles, not because of their same identity, but simply because the spread is greater over 2D 
space. Compared with separation on BPX50/BPX5, a smaller number of components has been detected; 
however, they show good peak shape and they were better spread on the 2D plot. It seems the separation 
mechanism of DB-1, based on weaker aromatic and hydrogen bonding, but strong van der Waals interaction, 
shows higher discrimination of the cocaine and heroin constituents, thus better spread on the 2D column.
Figure 3.8 2D plot of volatiles in heroin sample Ha analysed by SPME on BP20/DB-1 column set
BPX5/BPX50
The separation of volatiles in cocaine samples on NP–P column sets was initially conducted on the BPX5/
BPX50 column set (see Figure 3.9A). While slightly increased peak signal for components was obtained 
when compared with BPX50/BPX5 column set, and significantly more components detected than in case of 
BP20/DB-1, the components are located in a rather narrow band on the 2D plot along the 1D time, showing 
poor spread on 2D space. The ‘orthogonality’ of this column set based on the different aromaticity content 
of the two phases (5% vs 50%) does not work well for cocaine constituents. The poor spread on 2D plot is 
undesirable in GC×GC, which makes the column set unsuitable for analysis of volatiles since it does not offer 
much advantage over classical 1D GC separation. Similar to the separation on BPX50/BPX5, good peak 
shape has been obtained. Again, similar results for spread of components on 2D plots have been obtained 
also for volatiles in heroin samples (see Figure 3.9B)
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Figure 3.9 2D plot of cocaine sample Cc (A) and heroin sample Ha (B) analysed by SPME on BPX5/BPX50 
column set. Note that the same contour levels are used in all FID 2D plots)
A
B
BPX5/BP20
BPX5/BP20 was the second NP–P column set tested for volatiles in cocaine and heroin. It has shown better 
spread of components on the 2D space, as well as good peak shape (see Figure 3.10). This column set 
revealed the highest number of separated volatiles in cocaine and heroin samples compared with the other 
column sets, offering complex sample profiles for easier (or reliable) sample discrimination. The ‘orthogonality’ 
of this column set, based on strong van der Waals and weak aromatic interactions of BPX5 phase versus 
strong H-bonding and weak π- and van der Waals bondings of the BP20 column, is more discriminative 
towards heroin and cocaine volatile constituents.
A sample GC×GC-FID profile of volatiles and semi-volatiles in cocaine is shown in Figure 3.10 along with a 2D 
plot of a blank, where only a few siloxanes are detected as background components. However, unambiguous 
identification of the components is necessary in order to avoid comparison of samples based on non-origin 
related markers. Unfortunately, a high number of reference components are required for GC×GC-FID to 
identify all components. Because of this, all further experiments were conducted on this column set, including 
the application employing a FPD.
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Figure 3.10 Representative 2D plot of (A) cocaine sample Cc analysed by SPME on BPX5/BP20 column set at 
0°C modulation temperature and 5 s modulation period, along with (B) a 2D plot of a blank, analysed under 
the same conditions
A
B
By contrast with heroin volatile profiles of samples Ha, Hb and Hc on BPX50/BPX5 (given in Figure 
3.6), profiles on BPX5/BP20 generated more individual components and could serve as reliable sample 
comparisons based on much more individually separated components. A closer look at the heroin profiles in 
Figure 3.11 can distinguish sample Ha from sample Hb and the differences are easily noticeable at the circled 
regions. Differentiation of these two samples on the other column set was almost impossible. The largest 
spot in sample Hb at 1tR of 20–23 minutes is due to the high abundant peak of caffeine, which in fact is not a 
good component for sample comparison.
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Figure 3.11 Representative 2D plots of heroin samples Ha (A), Hb (B) and Hc (C) analyzed by SPME on BPX5/
BP20 column set at 0°C modulation temperature and 5 s modulation period, along with a 2D plot of a blank 
(D), analysed under the same conditions. Note the difference in the Ha and Hb profiles at circled regions
BPX5/BP20 with FPD
The findings for presence of S- and P-containing components in heroin and cocaine volatiles are similar to 
the findings for ecstasy volatiles. Very few components at similar ratio have been detected on both, S- and 
P-channel, which makes this highly selective and sensitive detector not suitable for profiling purposes.
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Cocaine and heroin volatiles profiling on GC×GC-TOFMS
GC×GC-TOFMS separation and identification were conducted on BPX5/BP20 column set under the same 
conditions as in GC×GC-FID experiments, with two differences: 1.4m 2D column was replaced with 1m long 
2D column of the same type and helium was used as a carrier gas instead of hydrogen. The reason was to 
avoid any wraparounds and still to keep good spread of the components on 2D plots.
Identification and location of components on GC×GC-TOFMS
As expected, most of the higher molecular weight components usually used in cocaine and heroin profiling 
have not been detected in profiles by SPME sampling and TOFMS as a detector. The main reason, beside the 
low concentration of some of them, is the sampling technique. Some are not amenable for direct detection 
without prior reduction and/or derivatisation (ie truxillines). Head space SPME is generally not efficient in 
sampling higher molecular weight components, components which show low vapour pressure and polar 
components on polydimethylsiloxane/divinylbenzene. However, GC×GC-TOFMS chromatograms of volatiles 
and semi-volatiles in four different cocaine samples (see Figure 3.12) have revealed a large number of 
components, some of them as potentially good markers for profiling purpose.
Good spread of the volatiles on this column set has also been obtained for heroin samples. Figure 3.13 
shows different profiles of different heroin samples seized in Australia. It is well known that highly purified 
heroin samples from SEA (the majority of heroin samples seized in Australia come from this region) have 
simple organic impurity profiles making them unsuitable for sample-to-sample discrimination. However, volatile 
profiles of these samples are of reasonable complexity and represent a good base for selecting many markers 
for sample discrimination. The huge peak at 1tR of 1350 s in Figure 3.13A and Figure 3.13C is due to the 
heavy sample adulteration with caffeine.
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Figure 3.12 Representative GC×GC-TOFMS 2D plots of cocaine samples (A) Ca, (B) Cb, (C) Cc and (D) a 
cocaine sample seized in Australia, analysed on BPX5/BP20 column set. Visually different profiles have been 
obtained for different samples
By contrast with the previous methods for volatile profiling (Dujourdy & Besacier 2008), where components 
eluting up to acetophenone (RMM 120) have been selected for profiling, in the present method components 
with a molecular weight up to 289 (norcocaine) have been detected. The list of components preliminarily 
selected for cocaine profiling purposes consisted of 23 components (see Table 3.1) and the list of selected 
components for heroin profiling consisted of 17 components (see Table 3.2). 
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Figure 3.13 Representative GC×GC-TOFMS 2D plots of heroin samples (A) JP, (B) JP1, (C) JP2 and (D) JP3 
seized in Australia, analysed on BPX5/BP20 column set. Visually different profiles have been obtained for 
different samples
Some of them are well known as constituents of cocaine (tropanone, ecgonidine ME, EME, tropacocaine and 
norcocaine) and heroin samples (meconine, hydroxycotarnine, acetyl codeine), some of them are structurally 
similar to cocaine-related (methyl benzoate, trimethoxybenzaldehyde, methyl- and ethyl cinnamate) and 
heroin- or opium-related components (cresol acetate isomers, 4-methoxy quinoline) and are related or 
possibly related to them, but many of them apparently have not been previously reported as cocaine (PMK, 
1-methyl pyrrole, 6-caprolactam) or heroin sample constituents (trimethoxy benzene, 3,4- and 3,5-dimethoxy 
benzaldehyde, xanthene isomers) and therefore their origin is unknown. An extensive study on a larger 
number of samples is required in order to establish a strong relation between these components and their 
origin. However, most of them are prevalent in all analysed cocaine samples, with few exceptions where 
some selected components are unique for Macedonian or Australian samples. The latter makes classification 
according the country of seizure trivial. Highly purified heroin samples, supposed to originate from SEA 
(samples seized in Australia), lack many of the components selected for profiling making classification 
between SEA and SWA samples trivial. However, the lack of markers in these samples make differentiation of 
samples within a region difficult and probably sample amount increasing is seeing as possible solution.
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The list of components for cocaine profiling can be further extended with components frequently encountered 
in cocaine samples but originating from solvents, or impurities in solvents, used in cocaine extraction and 
purification. Toluene, xylene isomers, ethyl benzene, trimethyl benzenes, straight chain hydrocarbons, benzyl 
alcohol, benzoic acid etc are detected in many cocaine samples, but they are not taken into consideration. 
In the same manner, acetic acid, toluene, xylene isomers, phenyl acetate, benzaldehyde etc are detected in 
heroin samples but not taken for profiling purpose.
The lowest boiling point solvents such as methanol, ethanol, acetone, diethyl ether, methylene chloride etc are 
not determined because of their poor trapping at the operating temperature of the modulator (-30°C to 0°C). 
Formation of some degradation products due to the long equilibration and absorption time (70 minutes in 
total) even though unlikely is not excluded. However, such a confirmation requires an extensive research.
A number of pyridine and quinoline derivatives have been detected in some cocaine samples from Macedonia 
only, which probably represent a unique profile of samples that originated from that batch or particular supply 
chain. Two pesticides (γ-lindane and trifluraline) have been detected at different level in all three cocaine 
samples from Macedonia and in one sample from Australia, which could be possible good batch markers 
if they originate from the coca crop treatment. Their presence in the samples has been confirmed by GC-
accTOFMS with an average mass accuracy of less than five ppm.
Table 3.1 Selected 23 components for cocaine profiling with their retention times, ions used for area 
calculation and similarity against NIST05 and Wiley7 MS libraries
Component 1tR 2tR Similaritya Quant. ion (m/z) RMMb
1 1-methyl pyrrole 340 1.64 946 81 81
2 Phenylmethyl ketone 700 2.04 961 120 120
3 methyl benzoate 725 1.76 938 136 136
4 2,5-pyrrole-dione 750 3.22 947 113 113
5 methyl nicotinate 775 2.12 943 137 137
6 1-phenyl-1,2-propanedione 800 2.06 952 105 148
7 Tropanone 835 1.92 905 139 139
8 6-caprolactam 905 3.34 940 113 113
9 α-oxo-benzeneacetic acid 
methyl ester
915 2.40 966 105 164
10 2-chloroacetophenone 915 2.66 956 105 154
11 ecgonidine methyl ester 1010 1.56 809 181 181
12 ecgonine methyl ester 1085 1.80 899 199 199
13 4-ethoxybenzoic acid ethyl 
ester
1100 1.68 930 194 194
14 Unknown-1 1110 2.18 199
15 3,4,5-triMeObenzaldeh 1165 2.38 925 196 196
16 phenyl benzoate 1210 1.64 972 105 198
17 2-ethylhexyl benzoate 1260 1.02 888 105 234
18 (4-chlorophenyl)phenyl 
methanone
1355 1.56 907 216 216
19 Tropacocaine 1430 1.76 909 245 245
20 Unknown-2 1445 1.30 182
21 1,3-diphenyl-1,3-
propanedione
1505 3.42 904 223 224
22 Norcocaine 1600 3.52 928 168 289
23 Unknown-3 1755 2.96 105
a Calculated from duplicate analysis obtained from samples where the component has been detected at S/N of 100 or above
b RMM: relative molecular mass
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Once the full mass spectra of the matrix are retained, cutting agents and other non-target components can be 
easily included in the list if such is needed. On average 400 components out of 1,400–1,700 detected in total 
have been tentatively identified in the samples with similarity above 800 and S/N threshold of 100. Although 
several tens are background components (mainly siloxanes from the SPME fibre and column phase bleeding) 
the majority are still cocaine and heroin related components.
Table 3.2 Selected 17 components for heroin profiling with their retention times, ions used for area 
calculation and similarity against NIST05 and Wiley7 MS libraries
Name 1tR 2tR Similarity Quant. ion 
(m/z)
1 4-cresol acetate 770 1.76 941 150
2 3-cresol acetate 805 1.76 904 150
3 1,2,4-trimethoxybenzene 975 2.02 945 168
4 3,5-dimethoxybenzaldehyde 1060 2.18 918 166
5 3,4-dimethoxybenzaldehyde 1090 2.44 926 166
6 4-methoxyquinoline 1135 2.34 850 159
7 3,4-dimethoxybenzyl acetate 1165 2.14 835 210
8 Xanthene isomer 1 1195 1.64 - 181
9 Xanthene isomer 2 1205 1.74 - 181
10 Xanthene isomer 3 1215 1.76 - 181
11 Unknown 197 isomer 1 1210 1.20 - 197
12 Unknown 197 isomer 2 1215 1.26 - 197
13 Unknown 197 isomer 3 1250 1.32 - 197
14 meconine 1275 3.78 885 194
15 hydrocotarnine 1320 1.92 840 220
16 Acetyl codeine 1395 3.44 827 341
17 trifluralin 1200 1.26 810 306
The success of this study can be attributed to the improved separation based on two ‘orthogonal’ separation 
mechanisms, to the enhanced sensitivity due to the compression effect of the modulator and to the powerful 
deconvolution capabilities of the LECO ChromaTOF software facilitated by the high acquisition rate. GC×GC-
TOFMS offers unprecedented information content for volatiles and semi-volatiles in cocaine and heroin 
samples. The high match quality of TOFMS spectra against commercial MS databases (NIST05 and Wiley7) 
agreed with our previous conclusion (Mitrevski et al. 2008; Mitrevski, Wilairat & Marriott 2010a) that match 
quality decreases as molecular weight and thus mass fragments in the mass spectra increases. The general 
trend of similarity decreasing as molecular weight increases, as calculated for the components given in Table 
3.1, is shown in Figure 3.14. The average similarity of selected cocaine profiling components (excluding 2 
outliers) was 925 and the average similarity for the identified heroin components was 880. The lower average 
similarity for heroin components is probably contributed to by their higher average molecular mass (data not 
given) when compared with cocaine components. The high similarity of TOFMS spectra to the commercial 
library entries excludes the need for TOFMS dedicated in-house library, one which was necessary in our study 
on sterols and anabolic agents (Mitrevksi et al. 2008; Mitervski, Wilairat & Marriott 2010a, 2010b).
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Figure 3.14 The average similarity of TOFMS spectra of selected volatiles in cocaine samples against NIST05 
and Wiley7, versus their molecular weight
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Conclusion
The method presented here represents a compromise between the complex and time consuming profiling 
methods offering high information content and much simpler methods based on major components profiling 
which offer limited information content. Even though the method lacks some components usually used in 
profiling of cocaine and heroin (mainly higher molecular mass components), the method offers clear and 
trivial discrimination between samples from different countries and more importantly, discrimination between 
samples from the same country (region). This is especially valuable for highly purified heroin samples usually 
originating from SEA region, where the lack of impurities in the profiles prevents their discrimination.
Volatile and semi-volatile component profiles are complex, containing great number of compounds for reliable 
comparison. However, the number of resolved components is strongly related to the column configuration 
applied for separation, and BPX5/BP20 has been shown to offer maximum spread on the 2D plots for both, 
heroin and cocaine volatiles. It seems the orthogonal separation mechanisms of BPX5 phase based on strong 
π-π* interaction and BP20 phase based on strong hydrogen bonding are best suited for volatiles in cocaine 
and heroin samples. This gives different profile patterns of samples with maximum number of individually 
separated components, which in turn offers most reliable sample comparison and differentiation.
The lists of cocaine and heroin selected components for profiling can be further extended with new 
components from profiles once a good relationship is established between them and their origin in the 
samples. Solvents used in the preparation of drugs, as well as their impurities, are good markers for sample-
to-sample comparison and can be easily added to the list. Exceptions are lowest boiling point solvents such 
as diethyl ether, ethanol, methanol, acetone etc which are not amenable for proper modulation in GC×GC 
format at the operating temperature of LMCS.
The full mass spectral data of non-targets and matrix components retained due to the TOFMS detector 
capabilities permit many more components to be used as markers; some of them could be very unique for 
particular group of samples or geographic origin. Pesticides used in crop treatment could be potentially good 
geographic origin markers once strong relationships are established between their presence in samples and 
regions of their use.
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Appendix
The following publications and reports were prepared by Professor Marriott and PhD student Mr Blagoj 
Mitrevski during the period of the NDLERF Grant. Mr Mitrevski was primarily responsible for the illicit drugs 
profiling work and was assigned the task of undertaking the NDLERF project. However, he held an IPRS grant 
and under this grant it was decided that two parallel studies would be conducted, namely:
•	 steroids analysis; and
•	 illicit drugs analysis.
For completeness, studies in both these areas will be reported here, since this represents aspects of learning 
the technology that was developed for steroids and then later applied to illicit drugs analysis.
Refereed journals
1. Blagoj Mitrevski, J. Thomas Brenna, Y. Zhang and Philip J. Marriott 
A new paradigm in drugs analysis: comprehensive two-dimensional gas chromatography for steroid 
analysis 
Chemistry in Australia, 74 (Nov) (2007) 3-5 ERA Ranking -
2. Shin Miin Song, Blagoj Mitrevski and Philip J. Marriott 
Chemical Fingerprinting of Illicit Drug Seizures—2D Profiling Using Novel GC Methods 
Chemistry in Australia, 75 (April) (2008) 20-22 ERA Ranking -
3. Blagoj S. Mitrevski, J. Thomas Brenna, Y. Zhang, Philip J. Marriott 
Application of Comprehensive Two-dimensional Gas Chromatography to Sterols Analysis 
Journal of Chromatography, A, 1214 (2008) 134–142; ERA Ranking A+
4. Blagoj Mitrevski, Konstantinos Kouremenos and Philip J. Marriott 
Accelerating analysis for metabolomics, drugs and their metabolites in biological samples using 
multidimensional methods in gas chromatography 
Bioanalysis I(2) (2009) 367-391, ERA Ranking -
5. Jacqui Adcock, Mike Adams, Blagoj Mitrevski, and Philip Marriott 
Peak modeling approach to accurate assignment of first-dimension retention times in comprehensive 
twodimensional chromatography 
Analytical Chemistry, 81 (2009) 6797-6804 ERA Ranking A+
6. Blagoj S. Mitrevski, Prapin Wilairat and Philip J. Marriott 
Improvement of Separation and Identification of Anabolic Agents in Doping Control: GC´GC-TOFMS as a 
New Tool 
Accepted for publication in Journal of Chromatography A. 2010 ERA Ranking A+
7. Blagoj S. Mitrevski, Prapin Wilairat, Philip J. Marriott. 
Comprehensive Two-Dimensional Gas Chromatography – Time-of-Flight Mass Spectroscopy Method 
Performance Against World Anti-doping Agency Identification Criteria 
Accepted for publication in Analytical and Bioanalytical Chemistry. 2010 ERA Ranking B.
8. Blagoj S. Mitrevski, Philip J. Marriott (additional authorship TBA).  
Illicit Drug Profiling by Using Comprehensive Two-Dimensional Gas Chromatography and Chemometric 
Analysis 
Manuscript In Preparation, Jan 2010
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Innovative solutions for enhanced illicit drugs profiling using comprehensive two-dimensional gas chromatography and 
mass spectrometry technologies
Conference presentations
Philip Marriott and Blagoj Mitrevski
Design of a comprehensive two-dimensional gas chromatography (GC×GC) system for drugs analysis
Invited Keynote Lecture. Asianalysis Jeju, Korea, 7-9 November 2007 
Philip J. Marriott, Tin Tran, Blagoj Mitrevski
Studies in comprehensive two-dimensional gas chromatography / mass spectrometry
Invited Lecture, ANZSMS22 Biennial Mass Spectrometry Conference, Sydney, 27-30 January 2009
Blagoj Mitrevski and Philip Marriott
Separation and identification of endogenous sterols by using comprehensive two-dimensional gas 
chromatography
Singapore International Chemistry Conference 5 (SICC5) and 7th Asia Pacific International Symposium on 
Microscale Analysis and Separation (APCE 2007). 17-19 December 2007 
Blagoj Mitrevski, Philip Marriot and Prapin Wilairat
Application of GCxGC-TOFMS for detection and confirmation of anabolic substances in doping control
Oral Presentation, 16th Annual Topics in Research and Development Meeting, 6-9 December 2008, 
Macquarie University, Sydney
Blagoj Mitrevski, Philip Marriott and Prapin Wilairat
Application of GCxGC-TOFMS for detection and confirmation of anabolic substances in doping control 
Poster presentation, ACROSS Symposium, University of Tasmania, Hobart, 8-10 December 2008, 
J. T. Brenna, Y. Zhang, H.J. Tobias, G.L. Sacks, B.S. Mitrevski, P.J. Marriott
Urinary Steroidomics by Comprehensive Two Dimensional Gas Chromatography-TOFMS (2D GC×GC-
TOFMS) and Isotope Ratio Mass Spectrometry (IRMS). Instrumentation and Application to Sports Antidoping
ASMS 2009. Sanibel Meeting, Lipidomics and Lipids in Mass Spectrometry. January 23 - 26, 2009 
TradeWinds Island Grand Hotel, St. Petersburg Beach, Florida 
Blagoj Mitrevski, Prapin Wilairat and Philip J. Marriott
GCxGC-TOFMS improves the separation and identification of anabolic agents in doping control
TIAFT Confence, Geneva, Switzerland August 2009
Other Reports
Marriott, Philip J, Mitrevski, Blagoj 
Australian research tackles drug cheats 
Television News segment broadcast on Australia Network News, 25 November 2009. 
www.australianetworknews.com
Travel
Mr. Blagoj Mitrevski presented his most recent research data in WADA Anabolic Agents analysis at The 
International Association of Forensic Toxicologists (TIAFT) held in Geneva, Switzerland in August 2009. In 
association with this visit, he also returned to his home in Macedonia to consult with his former laboratory 
which services the analysis of street capture drugs, and which had supplied him with samples of drugs, the 
analysis of which were reported in the previous report. 
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